{"id":1388,"date":"2026-01-20T19:06:38","date_gmt":"2026-01-20T19:06:38","guid":{"rendered":"https:\/\/psocan.marketaccess.ca\/traitements-traiter-le-pso-et-le-psa-vue-densemble\/applications-topiques\/"},"modified":"2026-03-19T18:50:21","modified_gmt":"2026-03-19T18:50:21","slug":"applications-topiques","status":"publish","type":"page","link":"https:\/\/psoriasiscanada.ca\/fr\/traitements-traiter-le-pso-et-le-psa-vue-densemble\/applications-topiques\/","title":{"rendered":"Applications topiques"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"1388\" class=\"elementor elementor-1388 elementor-798\" data-elementor-post-type=\"page\">\n\t\t\t\t<div class=\"elementor-element elementor-element-10557271 e-flex e-con-boxed e-con e-parent\" data-id=\"10557271\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-a861396 elementor-widget elementor-widget-heading\" data-id=\"a861396\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h1 class=\"elementor-heading-title elementor-size-default\">Applications topiques<\/h1>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-261d49f7 elementor-widget elementor-widget-text-editor\" data-id=\"261d49f7\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p>Un \u00e9mollient est un ingr\u00e9dient pr\u00e9sent dans les traitements topiques pour adoucir et apaiser la peau. Ils constituent des options de traitement pr\u00e9cieuses et peu co\u00fbteuses pour de nombreuses personnes atteintes de psoriasis l\u00e9ger \u00e0 mod\u00e9r\u00e9. Lorsque le psoriasis est plus grave, les solutions topiques sont susceptibles d\u2019\u00eatre associ\u00e9es \u00e0 des m\u00e9dicaments par voie orale, \u00e0 la phototh\u00e9rapie ou \u00e0 des m\u00e9dicaments biologiques.  <\/p><p>Les \u00e9mollients soulagent les sympt\u00f4mes de s\u00e9cheresse et d\u2019irritation tout en aidant \u00e0 g\u00e9rer la prolif\u00e9ration et l\u2019excr\u00e9tion des cellules cutan\u00e9es qui surviennent chez les personnes atteintes de psoriasis. Ils peuvent contribuer \u00e0 adoucir les plaques et les fissures, \u00e0 am\u00e9liorer la capacit\u00e9 de la peau \u00e0 retenir l\u2019eau et \u00e0 cr\u00e9er une barri\u00e8re qui prot\u00e8ge la peau des bact\u00e9ries et autres irritants. Par cons\u00e9quent, cela am\u00e9liore la fonction de barri\u00e8re de la peau et soulage l\u2019inflammation. Les \u00e9mollients se pr\u00e9sentent sous de nombreuses formes diff\u00e9rentes, comme les cr\u00e8mes, les pommades, les onguents, les mousses, les a\u00e9rosols, les gels et les shampoings, et peuvent \u00eatre utilis\u00e9s directement sur la peau.   <\/p><p>Les agents humectants et occlusifs sont les deux ingr\u00e9dients cl\u00e9s d\u2019un produit hydratant. La combinaison des ingr\u00e9dients d\u00e9termine l\u2019utilisation et la consistance d\u2019un produit. L\u2019humectant am\u00e9liore la capacit\u00e9 de la peau \u00e0 retenir l\u2019eau et l\u2019agent occlusif ralentit la perte d\u2019eau en cr\u00e9ant une barri\u00e8re protectrice \u00e0 la surface de la peau.  <sup>  <\/sup>Ces ingr\u00e9dients peuvent sembler \u00e9pais et collants, c\u2019est pourquoi les fabricants les associent \u00e0 d\u2019autres substances pour am\u00e9liorer leur capacit\u00e9 \u00e0 se r\u00e9pandre et \u00e0 p\u00e9n\u00e9trer dans la peau. Les produits plus \u00e9pais sont souvent un bon choix pour les personnes atteintes de psoriasis, car ils peuvent pr\u00e9venir la s\u00e9cheresse, mais il est pr\u00e9f\u00e9rable de consulter un m\u00e9decin pour d\u00e9terminer le traitement id\u00e9al. <\/p><p>Lorsque vous choisissez une cr\u00e8me hydratante pour le psoriasis, vous pouvez \u00e9galement prendre en compte l\u2019odeur, la facilit\u00e9 d\u2019utilisation et les ingr\u00e9dients du produit. Les produits hypoallerg\u00e9niques (un produit contenant moins de substances allergisantes) sont couramment utilis\u00e9s, car ils sont moins susceptibles d\u2019irriter la peau. <sup> <\/sup>Certains parfums et produits chimiques pr\u00e9sents dans les cr\u00e8mes hydratantes peuvent aggraver la peau au lieu de soulager les sympt\u00f4mes, il est donc pr\u00e9f\u00e9rable de rechercher une cr\u00e8me sans parfum.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-9aacea8 elementor-widget elementor-widget-tablepress-table\" data-id=\"9aacea8\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"tablepress-table.default\">\n\t\t\t\t\t\n<table id=\"tablepress-4\" class=\"tablepress tablepress-id-4 tablepress-responsive\">\n<thead>\n<tr class=\"row-1\">\n\t<th class=\"column-1\">Type de produit<\/th><th class=\"column-2\">Consistence<\/th><th class=\"column-3\">Qualit\u00e9<\/th><th class=\"column-4\">Rapidit\u00e9 d\u2019absorption\/\u00e9vaporation apr\u00e8s l\u2019application sur la peau<\/th><th class=\"column-5\">Utile pour le traitement de parties pileuses<\/th><th class=\"column-6\">Autres consid\u00e9rations<\/th>\n<\/tr>\n<\/thead>\n<tbody class=\"row-striping row-hover\">\n<tr class=\"row-2\">\n\t<td class=\"column-1\"><strong>Onguent<\/strong><\/td><td class=\"column-2\">Visqueuse<\/td><td class=\"column-3\">Graisseuse<\/td><td class=\"column-4\">Lente<\/td><td class=\"column-5\">Non<\/td><td class=\"column-6\">Fournit une couche occlusive, lorsqu\u2019appliqu\u00e9 sur la peau<\/td>\n<\/tr>\n<tr class=\"row-3\">\n\t<td class=\"column-1\"><strong>Gel<\/strong><\/td><td class=\"column-2\">\u00c9paisse<\/td><td class=\"column-3\">Non-graisseuse<\/td><td class=\"column-4\">Mod\u00e9r\u00e9e<\/td><td class=\"column-5\">Non<\/td><td class=\"column-6\">Effet rafraichissant lorsqu\u2019appliqu\u00e9 sur la peau<\/td>\n<\/tr>\n<tr class=\"row-4\">\n\t<td class=\"column-1\"><strong>Cr\u00e8me<\/strong><\/td><td class=\"column-2\">Mod\u00e9r\u00e9e<\/td><td class=\"column-3\">Non-graisseuse \u00e0 l\u00e9g\u00e8rement graisseuse<\/td><td class=\"column-4\">Rapide<\/td><td class=\"column-5\">Possiblement<\/td><td class=\"column-6\"><\/td>\n<\/tr>\n<tr class=\"row-5\">\n\t<td class=\"column-1\"><strong>Lotion<\/strong><\/td><td class=\"column-2\">L\u00e9g\u00e8re<\/td><td class=\"column-3\">Non-graisseuse<\/td><td class=\"column-4\">Tr\u00e8s rapide<\/td><td class=\"column-5\">Oui<\/td><td class=\"column-6\">Effet rafraichissant lorsqu\u2019appliqu\u00e9e sur la peau<\/td>\n<\/tr>\n<tr class=\"row-6\">\n\t<td class=\"column-1\"><strong>Mousse<\/strong><\/td><td class=\"column-2\">L\u00e9g\u00e8re<\/td><td class=\"column-3\">Non-graisseuse<\/td><td class=\"column-4\">Tr\u00e8s rapide<\/td><td class=\"column-5\">Oui<\/td><td class=\"column-6\">S\u2019applique facilement<\/td>\n<\/tr>\n<tr class=\"row-7\">\n\t<td class=\"column-1\"><strong>Solution<\/strong><\/td><td class=\"column-2\">L\u00e9g\u00e8re<\/td><td class=\"column-3\">Non-graisseuse<\/td><td class=\"column-4\">Tr\u00e8s rapide<\/td><td class=\"column-5\">Oui<\/td><td class=\"column-6\"><\/td>\n<\/tr>\n<tr class=\"row-8\">\n\t<td class=\"column-1\"><strong>Solution pour le cuir chevelu<\/strong><\/td><td class=\"column-2\">Tr\u00e8s l\u00e9g\u00e8re<\/td><td class=\"column-3\">Non-graisseuse<\/td><td class=\"column-4\">Tr\u00e8s rapide<\/td><td class=\"column-5\">Oui<\/td><td class=\"column-6\"><\/td>\n<\/tr>\n<tr class=\"row-9\">\n\t<td class=\"column-1\"><strong>Vaporisateur<\/strong><\/td><td class=\"column-2\">L\u00e9g\u00e8re<\/td><td class=\"column-3\">Non-graisseuse<\/td><td class=\"column-4\">Tr\u00e8s rapide<\/td><td class=\"column-5\">Possiblement<\/td><td class=\"column-6\"><\/td>\n<\/tr>\n<tr class=\"row-10\">\n\t<td class=\"column-1\"><strong>Shampooing<\/strong><\/td><td class=\"column-2\">L\u00e9g\u00e8re n<\/td><td class=\"column-3\">Non-graisseuse<\/td><td class=\"column-4\">Rapide<\/td><td class=\"column-5\">Oui<\/td><td class=\"column-6\">Doit \u00eatre laiss\u00e9 sur le cuir chevelu pendant\u00a010 \u00e0 15\u00a0minutes avant le rin\u00e7age (suivre les instructions donn\u00e9es avec le produit)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<!-- #tablepress-4 from cache -->\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-a76b350 elementor-widget elementor-widget-heading\" data-id=\"a76b350\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Consid\u00e9rations sur la forme de la posologie<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-28bc962 elementor-hidden-widescreen elementor-hidden-desktop elementor-hidden-laptop elementor-hidden-tablet_extra elementor-hidden-tablet elementor-hidden-mobile_extra elementor-hidden-mobile elementor-widget elementor-widget-html\" data-id=\"28bc962\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"html.default\">\n\t\t\t\t\t<!-- Responsive, accessible table (matches the screenshot styling closely) --><style>.vehicle-table {\n    --header-bg: #f39a3c;\n    --border: #d9d9d9;\n    --row-alt: #f3f3f3;\n    --text: #222;\n\n    max-width: 1100px;\n    margin: 0 auto;\n    color: var(--text);\n    font-family: system-ui, -apple-system, Segoe UI, Roboto, Arial, sans-serif;\n  }\n\n  .vehicle-table .table-wrap {\n    border: 2px solid var(--border);\n    border-radius: 10px;\n    overflow: hidden; \/* keeps rounded corners on header *\/\n    background: #fff;\n  }\n\n  .vehicle-table table {\n    width: 100%;\n    border-collapse: separate;\n    border-spacing: 0;\n  }\n\n  .vehicle-table th,\n  .vehicle-table td {\n    padding: 14px 16px;\n    border-right: 2px solid var(--border);\n    border-bottom: 2px solid var(--border);\n    vertical-align: top;\n    font-size: 16px;\n    line-height: 1.35;\n  }\n\n  .vehicle-table th:last-child,\n  .vehicle-table td:last-child {\n    border-right: 0;\n  }\n\n  .vehicle-table thead th {\n    background: var(--header-bg);\n    color: #000;\n    font-weight: 800;\n  }\n\n  .vehicle-table tbody tr:nth-child(even) td {\n    background: var(--row-alt);\n  }\n\n  .vehicle-table tbody tr:last-child td {\n    border-bottom: 0;\n  }\n\n  .vehicle-table td:first-child {\n    font-weight: 800; \/* Vehicle column bold *\/\n  }\n\n  \/* Column sizing (approx. to screenshot) *\/\n  .vehicle-table colgroup col:nth-child(1) { width: 11%; }\n  .vehicle-table colgroup col:nth-child(2) { width: 12%; }\n  .vehicle-table colgroup col:nth-child(3) { width: 14%; }\n  .vehicle-table colgroup col:nth-child(4) { width: 26%; }\n  .vehicle-table colgroup col:nth-child(5) { width: 13%; }\n  .vehicle-table colgroup col:nth-child(6) { width: 24%; }\n\n  \/* Mobile: turn into stacked \u201ccards\u201d *\/\n  @media (max-width: 860px) {\n    .vehicle-table .table-wrap {\n      border-radius: 12px;\n    }\n\n    .vehicle-table table,\n    .vehicle-table thead,\n    .vehicle-table tbody,\n    .vehicle-table th,\n    .vehicle-table td,\n    .vehicle-table tr {\n      display: block;\n      width: 100%;\n    }\n\n    .vehicle-table thead {\n      position: absolute;\n      left: -9999px; \/* keep accessible via DOM, visually hidden *\/\n      top: -9999px;\n    }\n\n    .vehicle-table tbody tr {\n      border-bottom: 2px solid var(--border);\n      background: #fff;\n    }\n\n    .vehicle-table tbody tr:nth-child(even) td {\n      background: #fff; \/* cards look cleaner *\/\n    }\n\n    .vehicle-table td {\n      border-right: 0;\n      border-bottom: 1px solid var(--border);\n      padding: 12px 14px;\n      display: grid;\n      grid-template-columns: minmax(140px, 42%) 1fr;\n      gap: 10px;\n      align-items: start;\n    }\n\n    .vehicle-table td:last-child {\n      border-bottom: 0;\n    }\n\n    .vehicle-table td::before {\n      content: attr(data-label);\n      font-weight: 800;\n    }\n\n    .vehicle-table td:first-child {\n      background: var(--row-alt);\n      border-bottom: 2px solid var(--border);\n      grid-template-columns: 1fr;\n    }\n\n    .vehicle-table td:first-child::before {\n      content: \"Vehicle\";\n      display: none; \/* already the value *\/\n    }\n\n    .vehicle-table tbody tr:last-child {\n      border-bottom: 0;\n    }\n  }\n<\/style><section class=\"vehicle-table\" aria-label=\"Topical vehicle comparison table\"><div class=\"table-wrap\"><table><colgroup><col \/><col \/><col \/><col \/><col \/><col \/><\/colgroup><thead><tr><th scope=\"col\">Vehicle<\/th><th scope=\"col\">Consistency<\/th><th scope=\"col\">Quality<\/th><th scope=\"col\">Speed of absorption\/evaporation after application to the skin<\/th><th scope=\"col\">Useful for areas with hair<\/th><th scope=\"col\">Other considerations<\/th><\/tr><\/thead><tbody><tr><td data-label=\"Vehicle\">Ointment<\/td><td data-label=\"Consistency\">Viscous<\/td><td data-label=\"Quality\">Greasy<\/td><td data-label=\"Speed of absorption\/evaporation after application to the skin\">Slow<\/td><td data-label=\"Useful for areas with hair\">No<\/td><td data-label=\"Other considerations\">Provides an occlusive layer when applied to skin<\/td><\/tr><tr><td data-label=\"Vehicle\">Gel<\/td><td data-label=\"Consistency\">Thick<\/td><td data-label=\"Quality\">Non-greasy<\/td><td data-label=\"Speed of absorption\/evaporation after application to the skin\">Moderate<\/td><td data-label=\"Useful for areas with hair\">No<\/td><td data-label=\"Other considerations\">Cooling sensation when applied to skin<\/td><\/tr><tr><td data-label=\"Vehicle\">Cream<\/td><td data-label=\"Consistency\">Moderate<\/td><td data-label=\"Quality\">Non-greasy to mildly greasy<\/td><td data-label=\"Speed of absorption\/evaporation after application to the skin\">Quick<\/td><td data-label=\"Useful for areas with hair\">Maybe<\/td><td data-label=\"Other considerations\"><\/td><\/tr><tr><td data-label=\"Vehicle\">Lotion<\/td><td data-label=\"Consistency\">Thin<\/td><td data-label=\"Quality\">Non-greasy<\/td><td data-label=\"Speed of absorption\/evaporation after application to the skin\">Very Quick<\/td><td data-label=\"Useful for areas with hair\">Yes<\/td><td data-label=\"Other considerations\">Cooling sensation when applied to skin<\/td><\/tr><tr><td data-label=\"Vehicle\">Foam<\/td><td data-label=\"Consistency\">Thin<\/td><td data-label=\"Quality\">Non-greasy<\/td><td data-label=\"Speed of absorption\/evaporation after application to the skin\">Very Quick<\/td><td data-label=\"Useful for areas with hair\">Yes<\/td><td data-label=\"Other considerations\">Spreads easily<\/td><\/tr><tr><td data-label=\"Vehicle\">Solution<\/td><td data-label=\"Consistency\">Thin<\/td><td data-label=\"Quality\">Non-greasy<\/td><td data-label=\"Speed of absorption\/evaporation after application to the skin\">Very Quick<\/td><td data-label=\"Useful for areas with hair\">Yes<\/td><td data-label=\"Other considerations\"><\/td><\/tr><tr><td data-label=\"Vehicle\">Scalp solution<\/td><td data-label=\"Consistency\">Very Thin<\/td><td data-label=\"Quality\">Non-greasy<\/td><td data-label=\"Speed of absorption\/evaporation after application to the skin\">Very Quick<\/td><td data-label=\"Useful for areas with hair\">Yes<\/td><td data-label=\"Other considerations\"><\/td><\/tr><tr><td data-label=\"Vehicle\">Spray<\/td><td data-label=\"Consistency\">Very Thin<\/td><td data-label=\"Quality\">Non-greasy<\/td><td data-label=\"Speed of absorption\/evaporation after application to the skin\">Very Quick<\/td><td data-label=\"Useful for areas with hair\">Maybe<\/td><td data-label=\"Other considerations\"><\/td><\/tr><tr><td data-label=\"Vehicle\">Shampoo<\/td><td data-label=\"Consistency\">Very Thin<\/td><td data-label=\"Quality\">Non-greasy<\/td><td data-label=\"Speed of absorption\/evaporation after application to the skin\">Quick<\/td><td data-label=\"Useful for areas with hair\">Yes<\/td><td data-label=\"Other considerations\">Must be left in place for 10-15 minutes before rinsing (follow product instructions)<\/td><\/tr><\/tbody><\/table><\/div><\/section>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-934bc50 elementor-hidden-widescreen elementor-hidden-desktop elementor-hidden-laptop elementor-hidden-tablet_extra elementor-hidden-tablet elementor-hidden-mobile_extra elementor-hidden-mobile elementor-widget elementor-widget-responsive_table\" data-id=\"934bc50\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"responsive_table.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"ert-responsive-table-wrapper\"><h3 class=\"ert-table-title\">Dosage Form Considerations<\/h3><div class=\"ert-table-container\"><table class=\"ert-table ert-borders\"><thead><tr class=\"ert-title-row\"><th scope=\"col\">Vehicle<\/th><th scope=\"col\">Consistency<\/th><th scope=\"col\">Quality<\/th><th scope=\"col\">Speed of absorption\/ evaporation after application to the skin<\/th><th scope=\"col\">Useful for areas with hair<\/th><th scope=\"col\">Other considerations<\/th><\/tr><\/thead><tbody><tr><th scope=\"row\" data-label=\"Vehicle\"><b>Ointment<\/b><\/th><td data-label=\"Consistency\">Viscous<\/td><td data-label=\"Quality\">Greasy<\/td><td data-label=\"Speed of absorption\/ evaporation after application to the skin\">Slow<\/td><td data-label=\"Useful for areas with hair\">No<\/td><td data-label=\"Other considerations\">Provides an occlusive layer when applied to skin<\/td><\/tr><tr><th scope=\"row\" data-label=\"Vehicle\"><b>Gel<\/b><\/th><td data-label=\"Consistency\">Thick<\/td><td data-label=\"Quality\">Non-greasy<\/td><td data-label=\"Speed of absorption\/ evaporation after application to the skin\">Moderate<\/td><td data-label=\"Useful for areas with hair\">No<\/td><td data-label=\"Other considerations\">\t Cooling sensation when applied to skin<\/td><\/tr><tr><th scope=\"row\" data-label=\"Vehicle\"><b>Cream<\/b><\/th><td data-label=\"Consistency\">Moderate<\/td><td data-label=\"Quality\">Non-greasy to mildly greasy<\/td><td data-label=\"Speed of absorption\/ evaporation after application to the skin\">Quick<\/td><td data-label=\"Useful for areas with hair\">Maybe<\/td><td data-label=\"Other considerations\"><\/td><\/tr><tr><th scope=\"row\" data-label=\"Vehicle\"><b>Lotion<\/b><\/th><td data-label=\"Consistency\">Thin<\/td><td data-label=\"Quality\">Non-greasy<\/td><td data-label=\"Speed of absorption\/ evaporation after application to the skin\">Very Quick<\/td><td data-label=\"Useful for areas with hair\">Yes<\/td><td data-label=\"Other considerations\">Cooling sensation when applied to skin<\/td><\/tr><tr><th scope=\"row\" data-label=\"Vehicle\"><b>Foam<\/b><\/th><td data-label=\"Consistency\">Thin<\/td><td data-label=\"Quality\">Non-greasy<\/td><td data-label=\"Speed of absorption\/ evaporation after application to the skin\">Very Quick<\/td><td data-label=\"Useful for areas with hair\">Yes<\/td><td data-label=\"Other considerations\">Spreads easily<\/td><\/tr><tr><th scope=\"row\" data-label=\"Vehicle\"><b>Solution<\/b><\/th><td data-label=\"Consistency\">Thin<\/td><td data-label=\"Quality\">Non-greasy<\/td><td data-label=\"Speed of absorption\/ evaporation after application to the skin\">Very Quick<\/td><td data-label=\"Useful for areas with hair\">Yes<\/td><td data-label=\"Other considerations\"><\/td><\/tr><tr><th scope=\"row\" data-label=\"Vehicle\"><b>Scalp solution<\/b><\/th><td data-label=\"Consistency\">Very Thin<\/td><td data-label=\"Quality\">Non-greasy<\/td><td data-label=\"Speed of absorption\/ evaporation after application to the skin\">Very Quick<\/td><td data-label=\"Useful for areas with hair\">Yes<\/td><td data-label=\"Other considerations\"><\/td><\/tr><tr><th scope=\"row\" data-label=\"Vehicle\"><b>Spray<\/b><\/th><td data-label=\"Consistency\">Very Thin<\/td><td data-label=\"Quality\">Non-greasy<\/td><td data-label=\"Speed of absorption\/ evaporation after application to the skin\">Very Quick<\/td><td data-label=\"Useful for areas with hair\">Maybe<\/td><td data-label=\"Other considerations\"><\/td><\/tr><tr><th scope=\"row\" data-label=\"Vehicle\"><b>Shampoo<\/b><\/th><td data-label=\"Consistency\">Very Thin<\/td><td data-label=\"Quality\">Non-greasy<\/td><td data-label=\"Speed of absorption\/ evaporation after application to the skin\">Quick<\/td><td data-label=\"Useful for areas with hair\">Yes<\/td><td data-label=\"Other considerations\">Must be left in place for 10-15 minutes before rinsing (follow product instructions)<\/td><\/tr><\/tbody><\/table><\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-568e35a e-flex e-con-boxed e-con e-parent\" data-id=\"568e35a\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-8576f52 elementor-widget elementor-widget-heading\" data-id=\"8576f52\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Liste des traitements topiques sur ordonnance<\/h2>\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-5aa03164 e-flex e-con-boxed e-con e-parent\" data-id=\"5aa03164\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-39821eb7 elementor-widget elementor-widget-n-accordion\" data-id=\"39821eb7\" data-element_type=\"widget\" data-e-type=\"widget\" data-settings=\"{&quot;default_state&quot;:&quot;all_collapsed&quot;,&quot;max_items_expended&quot;:&quot;one&quot;,&quot;n_accordion_animation_duration&quot;:{&quot;unit&quot;:&quot;ms&quot;,&quot;size&quot;:400,&quot;sizes&quot;:[]}}\" data-widget_type=\"nested-accordion.default\">\n\t\t\t\t\t\t\t<div class=\"e-n-accordion\" aria-label=\"Accordion. Open links with Enter or Space, close with Escape, and navigate with Arrow Keys\">\n\t\t\t\t\t\t<details id=\"e-n-accordion-item-9640\" class=\"e-n-accordion-item\" >\n\t\t\t\t<summary class=\"e-n-accordion-item-title\" data-accordion-index=\"1\" tabindex=\"0\" aria-expanded=\"false\" aria-controls=\"e-n-accordion-item-9640\" >\n\t\t\t\t\t<span class='e-n-accordion-item-title-header'><div class=\"e-n-accordion-item-title-text\"> Topical Corticosteroids (e.g., betamethasone &amp; mometasone) <\/div><\/span>\n\t\t\t\t\t\t\t<span class='e-n-accordion-item-title-icon'>\n\t\t\t<span class='e-opened' ><svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-minus\" viewBox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M416 208H32c-17.67 0-32 14.33-32 32v32c0 17.67 14.33 32 32 32h384c17.67 0 32-14.33 32-32v-32c0-17.67-14.33-32-32-32z\"><\/path><\/svg><\/span>\n\t\t\t<span class='e-closed'><svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-plus\" viewBox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M416 208H272V64c0-17.67-14.33-32-32-32h-32c-17.67 0-32 14.33-32 32v144H32c-17.67 0-32 14.33-32 32v32c0 17.67 14.33 32 32 32h144v144c0 17.67 14.33 32 32 32h32c17.67 0 32-14.33 32-32V304h144c17.67 0 32-14.33 32-32v-32c0-17.67-14.33-32-32-32z\"><\/path><\/svg><\/span>\n\t\t<\/span>\n\n\t\t\t\t\t\t<\/summary>\n\t\t\t\t<div role=\"region\" aria-labelledby=\"e-n-accordion-item-9640\" class=\"elementor-element elementor-element-5546256d e-con-full e-flex e-con e-child\" data-id=\"5546256d\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t<div role=\"region\" aria-labelledby=\"e-n-accordion-item-9640\" class=\"elementor-element elementor-element-782bb371 e-flex e-con-boxed e-con e-child\" data-id=\"782bb371\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-55878eb elementor-widget elementor-widget-text-editor\" data-id=\"55878eb\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<h4>Comment cela fonctionne-t-il ?<\/h4>\n<p>Les corticost\u00e9ro\u00efdes appliqu\u00e9s localement ont la capacit\u00e9 de r\u00e9duire l&#8217;inflammation de la peau dans de nombreuses affections, y compris le psoriasis.<\/p>\n<h4>Comment est-il utilis\u00e9 ?<\/h4>\n<p>Les corticost\u00e9ro\u00efdes topiques sont g\u00e9n\u00e9ralement prescrits pour \u00eatre appliqu\u00e9s sur les plaques psoriasiques deux fois par jour. Les corticost\u00e9ro\u00efdes topiques sont disponibles dans une vari\u00e9t\u00e9 de puissances (dosages) diff\u00e9rentes. Votre m\u00e9decin peut vous prescrire un corticost\u00e9ro\u00efde topique d&#8217;une certaine puissance en fonction de l&#8217;\u00e9paisseur des plaques de psoriasis et de leur emplacement sur votre corps.  <\/p>\n<h4>Quels sont les effets secondaires possibles ?<\/h4>\n<p>L&#8217;effet secondaire le plus courant des corticost\u00e9ro\u00efdes topiques est une l\u00e9g\u00e8re sensation de br\u00fblure ou de picotement apr\u00e8s l&#8217;application. L&#8217;utilisation \u00e0 long terme de corticost\u00e9ro\u00efdes puissants peut entra\u00eener un amincissement de la peau. Ce ph\u00e9nom\u00e8ne doit \u00eatre surveill\u00e9 par vous et votre m\u00e9decin.    <\/p>\n<h4>Y a-t-il d&#8217;autres points importants \u00e0 prendre en consid\u00e9ration ?<\/h4>\n<p>\u00c9vitez de couvrir les st\u00e9ro\u00efdes avec des bandages ou un film plastique, sauf si votre m\u00e9decin vous l&#8217;a demand\u00e9.<\/p>\n<h4>Quels sont les m\u00e9dicaments qui interagissent avec ce traitement ?<\/h4>\n<p>N\/A<\/p>\n<h4>Quelles provinces et quels territoires l&#8217;inscrivent sur leur liste de m\u00e9dicaments ?<\/h4>\n<p>Varie en fonction du corticost\u00e9ro\u00efde sp\u00e9cifique.<\/p>\n<h4>Monographie du produit<\/h4>\n<p data-pm-slice=\"1 1 []\">La monographie du produit est cr\u00e9\u00e9e par Sant\u00e9 Canada pour r\u00e9sumer les preuves qu&#8217;il a examin\u00e9es afin d&#8217;autoriser la vente de ce m\u00e9dicament aux patients au Canada. Elle comprend des informations sur l&#8217;indication du m\u00e9dicament (raison pour laquelle il est utilis\u00e9), ses effets secondaires et toute information relative aux avertissements de s\u00e9curit\u00e9. Ces informations sont utilis\u00e9es par les prescripteurs, les pharmaciens, les assureurs et d&#8217;autres personnes pour utiliser le m\u00e9dicament en toute s\u00e9curit\u00e9. Les informations peuvent \u00eatre tr\u00e8s d\u00e9taill\u00e9es et nous vous encourageons \u00e0 poser toutes les questions que vous souhaitez \u00e0 votre m\u00e9decin.   <\/p>\n<p><strong>Ce site est r\u00e9guli\u00e8rement mis \u00e0 jour, mais ces informations sont susceptibles d&#8217;\u00eatre modifi\u00e9es. Pour obtenir les informations les plus r\u00e9centes concernant les <u><a class=\"ProsemirrorEditor-link\" href=\"https:\/\/www.canadianpsoriasisnetwork.com\/provincial-territorial-programs\/\">monographies<\/a><\/u> monographies de produits, <u><a class=\"ProsemirrorEditor-link\" href=\"https:\/\/health-products.canada.ca\/dpd-bdpp\/?lang=eng\">faites une recherche ici<\/a><\/u>. <\/strong><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/details>\n\t\t\t\t\t\t<details id=\"e-n-accordion-item-9641\" class=\"e-n-accordion-item\" >\n\t\t\t\t<summary class=\"e-n-accordion-item-title\" data-accordion-index=\"2\" tabindex=\"-1\" aria-expanded=\"false\" aria-controls=\"e-n-accordion-item-9641\" >\n\t\t\t\t\t<span class='e-n-accordion-item-title-header'><div class=\"e-n-accordion-item-title-text\"> Analogues de la vitamine D3 (Dovonex\u00ae et Silkis\u00ae) <\/div><\/span>\n\t\t\t\t\t\t\t<span class='e-n-accordion-item-title-icon'>\n\t\t\t<span class='e-opened' ><svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-minus\" viewBox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M416 208H32c-17.67 0-32 14.33-32 32v32c0 17.67 14.33 32 32 32h384c17.67 0 32-14.33 32-32v-32c0-17.67-14.33-32-32-32z\"><\/path><\/svg><\/span>\n\t\t\t<span class='e-closed'><svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-plus\" viewBox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M416 208H272V64c0-17.67-14.33-32-32-32h-32c-17.67 0-32 14.33-32 32v144H32c-17.67 0-32 14.33-32 32v32c0 17.67 14.33 32 32 32h144v144c0 17.67 14.33 32 32 32h32c17.67 0 32-14.33 32-32V304h144c17.67 0 32-14.33 32-32v-32c0-17.67-14.33-32-32-32z\"><\/path><\/svg><\/span>\n\t\t<\/span>\n\n\t\t\t\t\t\t<\/summary>\n\t\t\t\t<div role=\"region\" aria-labelledby=\"e-n-accordion-item-9641\" class=\"elementor-element elementor-element-6e9a350 e-con-full e-flex e-con e-child\" data-id=\"6e9a350\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t<div role=\"region\" aria-labelledby=\"e-n-accordion-item-9641\" class=\"elementor-element elementor-element-bf40dd0 e-flex e-con-boxed e-con e-child\" data-id=\"bf40dd0\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-72598d4 elementor-widget elementor-widget-text-editor\" data-id=\"72598d4\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<h4>Comment cela fonctionne-t-il ?<\/h4><p>Les analogues de la vitamine <sub>D3<\/sub> agissent en r\u00e9gulant la production et la prolif\u00e9ration (accumulation) des cellules de la peau, qui sont anormales dans le psoriasis. Les analogues de la vitamine <sub>D3<\/sub> utilis\u00e9s pour traiter le psoriasis comprennent le calcitriol (<span class=\"reg\">Silkis\u00ae<\/span>) et le calcipotriol (<span class=\"reg\">Dovonex\u00ae<\/span>). <\/p><h4>Comment est-il utilis\u00e9 ?<\/h4><p>Les analogues de la vitamine D3 sont disponibles sous forme de pommades topiques et sont appliqu\u00e9s sur la zone cutan\u00e9e affect\u00e9e une ou deux fois par jour, selon les instructions du m\u00e9decin.<\/p><h4>Quels sont les effets secondaires possibles ?<\/h4><p>L&#8217;effet secondaire le plus courant des analogues de la vitamine <sub>D3<\/sub> est une sensation temporaire de br\u00fblure ou de picotement lors de l&#8217;application sur la peau.<\/p><h4>Y a-t-il d&#8217;autres points importants \u00e0 prendre en consid\u00e9ration ?<\/h4><p>N\/A<\/p><h4>Quels sont les m\u00e9dicaments qui interagissent avec ce traitement ?<\/h4><p>N\/A<\/p><h4>Tableaux du formulaire du programme public de m\u00e9dicaments<\/h4>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-560c6c9 elementor-widget elementor-widget-shortcode\" data-id=\"560c6c9\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"shortcode.default\">\n\t\t\t\t\t\t\t<div class=\"elementor-shortcode\">\n<table id=\"tablepress-1\" class=\"tablepress tablepress-id-1\">\n<thead>\n<tr class=\"row-1\">\n\t<th class=\"column-1\">Province<\/th><th class=\"column-2\">Class<\/th><th class=\"column-3\">Generic name<\/th><th class=\"column-4\">Drug Name<\/th><th class=\"column-5\">Psoriasis<\/th><th class=\"column-6\">Psoriatic arthritis<\/th><th class=\"column-7\">GPP<\/th><th class=\"column-8\">monograph<\/th>\n<\/tr>\n<\/thead>\n<tbody class=\"row-striping row-hover\">\n<\/tbody>\n<\/table>\n<!-- #tablepress-1 from cache -->\n\n<!-- HFCM by 99 Robots - Snippet # 5: add formulary text -->\n<p>More information is available on S\/A (special access), L\/U (limited use) and Exceptional Drug Status (EDS) at\u00a0<a href=\"https:\/\/www.canadianpsoriasisnetwork.com\/treatments-canada\/special-access-drugs\/\" target=\"_blank\" rel=\"noopener\">Special Access \/ Limited Use Designation Drugs<\/a>.<\/p><p>NIHB stands for <a href=\"https:\/\/www.sac-isc.gc.ca\/eng\/1572537161086\/1572537234517\" target=\"_blank\" rel=\"noopener\">non-insured health benefits<\/a>.<\/p><p>This site is updated regularly; however this information is subject to change. Access may also vary depending on the specific plan. For the most up-to-date information regarding\u00a0<a href=\"https:\/\/www.canadianpsoriasisnetwork.com\/provincial-territorial-programs\/\" target=\"_blank\" rel=\"noopener\">your specific province \/ territory click here<\/a>.<\/p>\n<!-- \/end HFCM by 99 Robots -->\n<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-9f8bc8b elementor-widget elementor-widget-text-editor\" data-id=\"9f8bc8b\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<h4>Monographie du produit<\/h4><p data-pm-slice=\"1 1 []\">La monographie du produit est cr\u00e9\u00e9e par Sant\u00e9 Canada pour r\u00e9sumer les preuves qu&#8217;il a examin\u00e9es afin d&#8217;autoriser la vente de ce m\u00e9dicament aux patients au Canada. Elle comprend des informations sur l&#8217;indication du m\u00e9dicament (raison pour laquelle il est utilis\u00e9), ses effets secondaires et toute information relative aux avertissements de s\u00e9curit\u00e9. Ces informations sont utilis\u00e9es par les prescripteurs, les pharmaciens, les assureurs et d&#8217;autres personnes pour utiliser le m\u00e9dicament en toute s\u00e9curit\u00e9. Les informations peuvent \u00eatre tr\u00e8s d\u00e9taill\u00e9es et nous vous encourageons \u00e0 poser toutes les questions que vous souhaitez \u00e0 votre m\u00e9decin.   <\/p><p><strong>Ce site est r\u00e9guli\u00e8rement mis \u00e0 jour, mais ces informations sont susceptibles d&#8217;\u00eatre modifi\u00e9es. Pour obtenir les informations les plus r\u00e9centes concernant les <u><a class=\"ProsemirrorEditor-link\" href=\"https:\/\/www.canadianpsoriasisnetwork.com\/provincial-territorial-programs\/\">monographies<\/a><\/u> monographies de produits, <u><a class=\"ProsemirrorEditor-link\" href=\"https:\/\/health-products.canada.ca\/dpd-bdpp\/?lang=eng\">faites une recherche ici<\/a><\/u>. <\/strong><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/details>\n\t\t\t\t\t\t<details id=\"e-n-accordion-item-9642\" class=\"e-n-accordion-item\" >\n\t\t\t\t<summary class=\"e-n-accordion-item-title\" data-accordion-index=\"3\" tabindex=\"-1\" aria-expanded=\"false\" aria-controls=\"e-n-accordion-item-9642\" >\n\t\t\t\t\t<span class='e-n-accordion-item-title-header'><div class=\"e-n-accordion-item-title-text\"> Combinaison d'analogues de la vitamine D3 et de corticost\u00e9ro\u00efdes (Dovobet\u00ae &amp; Enstilar\u2122) (Indisponible sur le site du CPN) <\/div><\/span>\n\t\t\t\t\t\t\t<span class='e-n-accordion-item-title-icon'>\n\t\t\t<span class='e-opened' ><svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-minus\" viewBox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M416 208H32c-17.67 0-32 14.33-32 32v32c0 17.67 14.33 32 32 32h384c17.67 0 32-14.33 32-32v-32c0-17.67-14.33-32-32-32z\"><\/path><\/svg><\/span>\n\t\t\t<span class='e-closed'><svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-plus\" viewBox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M416 208H272V64c0-17.67-14.33-32-32-32h-32c-17.67 0-32 14.33-32 32v144H32c-17.67 0-32 14.33-32 32v32c0 17.67 14.33 32 32 32h144v144c0 17.67 14.33 32 32 32h32c17.67 0 32-14.33 32-32V304h144c17.67 0 32-14.33 32-32v-32c0-17.67-14.33-32-32-32z\"><\/path><\/svg><\/span>\n\t\t<\/span>\n\n\t\t\t\t\t\t<\/summary>\n\t\t\t\t<div role=\"region\" aria-labelledby=\"e-n-accordion-item-9642\" class=\"elementor-element elementor-element-13a9691 e-con-full e-flex e-con e-child\" data-id=\"13a9691\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t<div role=\"region\" aria-labelledby=\"e-n-accordion-item-9642\" class=\"elementor-element elementor-element-09639cc e-flex e-con-boxed e-con e-child\" data-id=\"09639cc\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-b10575b elementor-widget elementor-widget-text-editor\" data-id=\"b10575b\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p>Prochainement.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/details>\n\t\t\t\t\t\t<details id=\"e-n-accordion-item-9643\" class=\"e-n-accordion-item\" >\n\t\t\t\t<summary class=\"e-n-accordion-item-title\" data-accordion-index=\"4\" tabindex=\"-1\" aria-expanded=\"false\" aria-controls=\"e-n-accordion-item-9643\" >\n\t\t\t\t\t<span class='e-n-accordion-item-title-header'><div class=\"e-n-accordion-item-title-text\"> R\u00e9tino\u00efdes topiques (Tazarot\u00e8ne) <\/div><\/span>\n\t\t\t\t\t\t\t<span class='e-n-accordion-item-title-icon'>\n\t\t\t<span class='e-opened' ><svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-minus\" viewBox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M416 208H32c-17.67 0-32 14.33-32 32v32c0 17.67 14.33 32 32 32h384c17.67 0 32-14.33 32-32v-32c0-17.67-14.33-32-32-32z\"><\/path><\/svg><\/span>\n\t\t\t<span class='e-closed'><svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-plus\" viewBox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M416 208H272V64c0-17.67-14.33-32-32-32h-32c-17.67 0-32 14.33-32 32v144H32c-17.67 0-32 14.33-32 32v32c0 17.67 14.33 32 32 32h144v144c0 17.67 14.33 32 32 32h32c17.67 0 32-14.33 32-32V304h144c17.67 0 32-14.33 32-32v-32c0-17.67-14.33-32-32-32z\"><\/path><\/svg><\/span>\n\t\t<\/span>\n\n\t\t\t\t\t\t<\/summary>\n\t\t\t\t<div role=\"region\" aria-labelledby=\"e-n-accordion-item-9643\" class=\"elementor-element elementor-element-68417c6 e-con-full e-flex e-con e-child\" data-id=\"68417c6\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t<div role=\"region\" aria-labelledby=\"e-n-accordion-item-9643\" class=\"elementor-element elementor-element-220a32c e-flex e-con-boxed e-con e-child\" data-id=\"220a32c\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-bf8297e elementor-widget elementor-widget-text-editor\" data-id=\"bf8297e\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<h4>Comment cela fonctionne-t-il ?<\/h4><p>Le m\u00e9canisme exact du tazarot\u00e8ne est inconnu. On pense qu&#8217;il joue un r\u00f4le dans la diff\u00e9renciation de la peau (c&#8217;est-\u00e0-dire qu&#8217;il aide \u00e0 contr\u00f4ler la multiplication des cellules de la peau) et qu&#8217;il peut \u00e9galement aider \u00e0 r\u00e9guler le syst\u00e8me immunitaire. <\/p><h4>Comment est-il utilis\u00e9 ?<\/h4><p>Le tazarot\u00e8ne se pr\u00e9sente sous forme de gel et de cr\u00e8me. Il est g\u00e9n\u00e9ralement recommand\u00e9 de l&#8217;appliquer sur la zone de peau affect\u00e9e une fois par jour, g\u00e9n\u00e9ralement le soir. Une am\u00e9lioration est g\u00e9n\u00e9ralement constat\u00e9e dans les deux mois suivant le traitement.  <\/p><h4>Quels sont les effets secondaires possibles ?<\/h4><p>L&#8217;effet secondaire le plus courant des r\u00e9tino\u00efdes topiques est l&#8217;irritation de la peau. Le tazarot\u00e8ne provoque souvent des rougeurs, une sensation de br\u00fblure, une s\u00e9cheresse de la peau et une desquamation, mais ces effets secondaires tendent \u00e0 dispara\u00eetre apr\u00e8s quelques semaines de traitement. <\/p><h4>Y a-t-il d&#8217;autres points importants \u00e0 prendre en consid\u00e9ration ?<\/h4><p>Le tazarot\u00e8ne ne peut pas \u00eatre utilis\u00e9 pendant la grossesse.<\/p><p>\u00c9vitez l&#8217;exposition non prot\u00e9g\u00e9e au soleil et aux lampes solaires, car ce produit peut augmenter la sensibilit\u00e9 de la peau aux rayons ultraviolets.<\/p><h4>Quels sont les m\u00e9dicaments qui interagissent avec ce traitement ?<\/h4><p>Aucune interaction m\u00e9dicamenteuse significative connue.<\/p><h4>Tableaux du formulaire du programme public de m\u00e9dicaments<\/h4>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-37d7e35 elementor-widget elementor-widget-shortcode\" data-id=\"37d7e35\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"shortcode.default\">\n\t\t\t\t\t\t\t<div class=\"elementor-shortcode\">\n<table id=\"tablepress-1-no-2\" class=\"tablepress tablepress-id-1\">\n<thead>\n<tr class=\"row-1\">\n\t<th class=\"column-1\">Province<\/th><th class=\"column-2\">Class<\/th><th class=\"column-3\">Generic name<\/th><th class=\"column-4\">Drug Name<\/th><th class=\"column-5\">Psoriasis<\/th><th class=\"column-6\">Psoriatic arthritis<\/th><th class=\"column-7\">GPP<\/th><th class=\"column-8\">monograph<\/th>\n<\/tr>\n<\/thead>\n<tbody class=\"row-striping row-hover\">\n<tr class=\"row-2\">\n\t<td class=\"column-1\">Alberta<\/td><td class=\"column-2\">Prescription Topical Treatments<\/td><td class=\"column-3\">Topical Retinoids (Tazarotene)<\/td><td class=\"column-4\">Arazlo<\/td><td class=\"column-5\">Yes<\/td><td class=\"column-6\">N\/A<\/td><td class=\"column-7\"><\/td><td class=\"column-8\">No information available<\/td>\n<\/tr>\n<tr class=\"row-3\">\n\t<td class=\"column-1\">British Columbia<\/td><td class=\"column-2\">Prescription Topical Treatments<\/td><td class=\"column-3\">Topical Retinoids (Tazarotene)<\/td><td class=\"column-4\">Arazlo<\/td><td class=\"column-5\">No<\/td><td class=\"column-6\">N\/A<\/td><td class=\"column-7\"><\/td><td class=\"column-8\">No information available<\/td>\n<\/tr>\n<tr class=\"row-4\">\n\t<td class=\"column-1\">Manitoba<\/td><td class=\"column-2\">Prescription Topical Treatments<\/td><td class=\"column-3\">Topical Retinoids (Tazarotene)<\/td><td class=\"column-4\">Arazlo<\/td><td class=\"column-5\">Yes<\/td><td class=\"column-6\">N\/A<\/td><td class=\"column-7\"><\/td><td class=\"column-8\">No information available<\/td>\n<\/tr>\n<tr class=\"row-5\">\n\t<td class=\"column-1\">New Brunswick<\/td><td class=\"column-2\">Prescription Topical Treatments<\/td><td class=\"column-3\">Topical Retinoids (Tazarotene)<\/td><td class=\"column-4\">Arazlo<\/td><td class=\"column-5\">Yes<\/td><td class=\"column-6\">N\/A<\/td><td class=\"column-7\"><\/td><td class=\"column-8\"><\/td>\n<\/tr>\n<tr class=\"row-6\">\n\t<td class=\"column-1\">Newfoundland and Labrador<\/td><td class=\"column-2\">Prescription Topical Treatments<\/td><td class=\"column-3\">Topical Retinoids (Tazarotene)<\/td><td class=\"column-4\">Arazlo<\/td><td class=\"column-5\">No<\/td><td class=\"column-6\">N\/A<\/td><td class=\"column-7\"><\/td><td class=\"column-8\">No information available<\/td>\n<\/tr>\n<tr class=\"row-7\">\n\t<td class=\"column-1\">NIHB<\/td><td class=\"column-2\">Prescription Topical Treatments<\/td><td class=\"column-3\">Topical Retinoids (Tazarotene)<\/td><td class=\"column-4\">Arazlo<\/td><td class=\"column-5\">Yes<\/td><td class=\"column-6\">N\/A<\/td><td class=\"column-7\"><\/td><td class=\"column-8\">No information available<\/td>\n<\/tr>\n<tr class=\"row-8\">\n\t<td class=\"column-1\">Northwest Territories<\/td><td class=\"column-2\">Prescription Topical Treatments<\/td><td class=\"column-3\">Topical Retinoids (Tazarotene)<\/td><td class=\"column-4\">Arazlo<\/td><td class=\"column-5\">Yes<\/td><td class=\"column-6\">N\/A<\/td><td class=\"column-7\"><\/td><td class=\"column-8\">No information available<\/td>\n<\/tr>\n<tr class=\"row-9\">\n\t<td class=\"column-1\">Nova Scotia<\/td><td class=\"column-2\">Prescription Topical Treatments<\/td><td class=\"column-3\">Topical Retinoids (Tazarotene)<\/td><td class=\"column-4\">Arazlo<\/td><td class=\"column-5\">SA<\/td><td class=\"column-6\">N\/A<\/td><td class=\"column-7\"><\/td><td class=\"column-8\">No information available<\/td>\n<\/tr>\n<tr class=\"row-10\">\n\t<td class=\"column-1\">Nunavut<\/td><td class=\"column-2\">Prescription Topical Treatments<\/td><td class=\"column-3\">Topical Retinoids (Tazarotene)<\/td><td class=\"column-4\">Arazlo<\/td><td class=\"column-5\">Yes<\/td><td class=\"column-6\">N\/A<\/td><td class=\"column-7\"><\/td><td class=\"column-8\">No information available<\/td>\n<\/tr>\n<tr class=\"row-11\">\n\t<td class=\"column-1\">Ontario<\/td><td class=\"column-2\">Prescription Topical Treatments<\/td><td class=\"column-3\">Topical Retinoids (Tazarotene)<\/td><td class=\"column-4\">Arazlo<\/td><td class=\"column-5\">No<\/td><td class=\"column-6\">N\/A<\/td><td class=\"column-7\"><\/td><td class=\"column-8\">No information available<\/td>\n<\/tr>\n<tr class=\"row-12\">\n\t<td class=\"column-1\">Prince Edward Island<\/td><td class=\"column-2\">Prescription Topical Treatments<\/td><td class=\"column-3\">Topical Retinoids (Tazarotene)<\/td><td class=\"column-4\">Arazlo<\/td><td class=\"column-5\">Yes<\/td><td class=\"column-6\">N\/A<\/td><td class=\"column-7\"><\/td><td class=\"column-8\">No information available<\/td>\n<\/tr>\n<tr class=\"row-13\">\n\t<td class=\"column-1\">Quebec<\/td><td class=\"column-2\">Prescription Topical Treatments<\/td><td class=\"column-3\">Topical Retinoids (Tazarotene)<\/td><td class=\"column-4\">Arazlo<\/td><td class=\"column-5\">No<\/td><td class=\"column-6\">N\/A<\/td><td class=\"column-7\"><\/td><td class=\"column-8\">No information available<\/td>\n<\/tr>\n<tr class=\"row-14\">\n\t<td class=\"column-1\">Saskatchewan<\/td><td class=\"column-2\">Prescription Topical Treatments<\/td><td class=\"column-3\">Topical Retinoids (Tazarotene)<\/td><td class=\"column-4\">Arazlo<\/td><td class=\"column-5\">Yes<\/td><td class=\"column-6\">N\/A<\/td><td class=\"column-7\"><\/td><td class=\"column-8\">No information available<\/td>\n<\/tr>\n<tr class=\"row-15\">\n\t<td class=\"column-1\">Yukon<\/td><td class=\"column-2\">Prescription Topical Treatments<\/td><td class=\"column-3\">Topical Retinoids (Tazarotene)<\/td><td class=\"column-4\">Arazlo<\/td><td class=\"column-5\">Yes<\/td><td class=\"column-6\">N\/A<\/td><td class=\"column-7\"><\/td><td class=\"column-8\">No information available<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<!-- #tablepress-1-no-2 from cache -->\n\n<!-- HFCM by 99 Robots - Snippet # 5: add formulary text -->\n<p>More information is available on S\/A (special access), L\/U (limited use) and Exceptional Drug Status (EDS) at\u00a0<a href=\"https:\/\/www.canadianpsoriasisnetwork.com\/treatments-canada\/special-access-drugs\/\" target=\"_blank\" rel=\"noopener\">Special Access \/ Limited Use Designation Drugs<\/a>.<\/p><p>NIHB stands for <a href=\"https:\/\/www.sac-isc.gc.ca\/eng\/1572537161086\/1572537234517\" target=\"_blank\" rel=\"noopener\">non-insured health benefits<\/a>.<\/p><p>This site is updated regularly; however this information is subject to change. Access may also vary depending on the specific plan. For the most up-to-date information regarding\u00a0<a href=\"https:\/\/www.canadianpsoriasisnetwork.com\/provincial-territorial-programs\/\" target=\"_blank\" rel=\"noopener\">your specific province \/ territory click here<\/a>.<\/p>\n<!-- \/end HFCM by 99 Robots -->\n<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-81f09e1 elementor-widget elementor-widget-text-editor\" data-id=\"81f09e1\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<h4>Monographie du produit<\/h4><p data-pm-slice=\"1 1 []\">La monographie est cr\u00e9\u00e9e par Sant\u00e9 Canada pour r\u00e9sumer les preuves qu&#8217;il a examin\u00e9es afin d&#8217;autoriser la vente de ce m\u00e9dicament aux patients au Canada. Elle comprend des informations sur l&#8217;indication du m\u00e9dicament (raison pour laquelle il est utilis\u00e9), ses effets secondaires et toute information relative aux avertissements de s\u00e9curit\u00e9. Ces informations sont utilis\u00e9es par les prescripteurs, les pharmaciens, les assureurs et d&#8217;autres personnes pour utiliser le m\u00e9dicament en toute s\u00e9curit\u00e9. Les informations peuvent \u00eatre tr\u00e8s d\u00e9taill\u00e9es et nous vous encourageons \u00e0 poser toutes les questions que vous souhaitez \u00e0 votre m\u00e9decin.   <\/p><p><strong>Ce site est r\u00e9guli\u00e8rement mis \u00e0 jour, mais ces informations sont susceptibles d&#8217;\u00eatre modifi\u00e9es. Pour obtenir les informations les plus r\u00e9centes concernant les <u><a class=\"ProsemirrorEditor-link\" href=\"https:\/\/www.canadianpsoriasisnetwork.com\/provincial-territorial-programs\/\">monographies<\/a><\/u> monographies de produits, <u><a class=\"ProsemirrorEditor-link\" href=\"https:\/\/health-products.canada.ca\/dpd-bdpp\/?lang=eng\">faites une recherche ici<\/a><\/u>. <\/strong><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/details>\n\t\t\t\t\t\t<details id=\"e-n-accordion-item-9644\" class=\"e-n-accordion-item\" >\n\t\t\t\t<summary class=\"e-n-accordion-item-title\" data-accordion-index=\"5\" tabindex=\"-1\" aria-expanded=\"false\" aria-controls=\"e-n-accordion-item-9644\" >\n\t\t\t\t\t<span class='e-n-accordion-item-title-header'><div class=\"e-n-accordion-item-title-text\"> Anthraline et goudrons <\/div><\/span>\n\t\t\t\t\t\t\t<span class='e-n-accordion-item-title-icon'>\n\t\t\t<span class='e-opened' ><svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-minus\" viewBox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M416 208H32c-17.67 0-32 14.33-32 32v32c0 17.67 14.33 32 32 32h384c17.67 0 32-14.33 32-32v-32c0-17.67-14.33-32-32-32z\"><\/path><\/svg><\/span>\n\t\t\t<span class='e-closed'><svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-plus\" viewBox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M416 208H272V64c0-17.67-14.33-32-32-32h-32c-17.67 0-32 14.33-32 32v144H32c-17.67 0-32 14.33-32 32v32c0 17.67 14.33 32 32 32h144v144c0 17.67 14.33 32 32 32h32c17.67 0 32-14.33 32-32V304h144c17.67 0 32-14.33 32-32v-32c0-17.67-14.33-32-32-32z\"><\/path><\/svg><\/span>\n\t\t<\/span>\n\n\t\t\t\t\t\t<\/summary>\n\t\t\t\t<div role=\"region\" aria-labelledby=\"e-n-accordion-item-9644\" class=\"elementor-element elementor-element-44f0dd7 e-con-full e-flex e-con e-child\" data-id=\"44f0dd7\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t<div role=\"region\" aria-labelledby=\"e-n-accordion-item-9644\" class=\"elementor-element elementor-element-e4b4eaf e-flex e-con-boxed e-con e-child\" data-id=\"e4b4eaf\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-2660930 elementor-widget elementor-widget-text-editor\" data-id=\"2660930\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<h4>Comment cela fonctionne-t-il ?<\/h4><p>Le m\u00e9canisme exact de l&#8217;anthraline et des goudrons n&#8217;est pas connu, mais on pense qu&#8217;ils diminuent l&#8217;inflammation de la peau associ\u00e9e au psoriasis. Le goudron de houille d\u00e9tache et ramollit les squames et les cro\u00fbtes. <\/p><h4>Comment est-il utilis\u00e9 ?<\/h4><p><strong>Anthraline :<\/strong><\/p><p>En g\u00e9n\u00e9ral, la cr\u00e8me est appliqu\u00e9e une fois par jour ou selon les instructions d&#8217;un m\u00e9decin ou d&#8217;un pharmacien. Au d\u00e9but de l&#8217;utilisation de l&#8217;anthraline, un temps de contact court de 5 \u00e0 10 minutes avec la cr\u00e8me peut \u00eatre conseill\u00e9 pendant la premi\u00e8re semaine de traitement. Le temps de contact peut \u00eatre progressivement augment\u00e9 jusqu&#8217;\u00e0 30 minutes, en fonction de la tol\u00e9rance de la peau. L&#8217;anthraline peut \u00eatre \u00e9limin\u00e9e en se lavant ou en prenant une douche.   <\/p><p>Lors de l&#8217;application, des gants peuvent \u00eatre utilis\u00e9s pour \u00e9viter de tacher les doigts et les ongles. Appliquer directement sur les plaques ; faire p\u00e9n\u00e9trer doucement et \u00e9viter d&#8217;appliquer sur la peau non affect\u00e9e. De la vaseline peut \u00eatre utilis\u00e9e sur les bords de la plaque pour \u00e9viter d&#8217;irriter la peau non affect\u00e9e.  <\/p><p><strong>Goudron de houille :<\/strong><\/p><p>Pour le psoriasis du cuir chevelu, le goudron de houille peut \u00eatre appliqu\u00e9 avec parcimonie sur les l\u00e9sions 3 \u00e0 12 heures avant le shampooing.<br>Pour le psoriasis corporel, appliquez du goudron de houille sur les l\u00e9sions au moment du coucher.<\/p><p>Lavez-vous les mains avant et apr\u00e8s l&#8217;application.<\/p><h4>Quels sont les effets secondaires possibles ?<\/h4><p>Anthraline : irritation temporaire de la peau, d\u00e9coloration temporaire des cheveux, d\u00e9coloration temporaire des ongles, d\u00e9coloration temporaire de la peau.<\/p><p>Goudron de houille : irritation temporaire de la peau, sensibilit\u00e9 accrue de la peau \u00e0 la lumi\u00e8re.<\/p><h4>Y a-t-il d&#8217;autres points importants \u00e0 prendre en consid\u00e9ration ?<\/h4><p>L&#8217;anthraline est irritante pour la peau normale environnante. Elle tache \u00e9galement la peau et les tissus. <\/p><p>Le goudron de houille a une odeur et peut tacher la peau et les cheveux.<\/p><h4>Quels sont les m\u00e9dicaments qui interagissent avec ce traitement ?<\/h4><p>N\/A<\/p><h4>Tableaux du formulaire du programme public de m\u00e9dicaments<\/h4><p>N\/A<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-c180a77 elementor-widget elementor-widget-text-editor\" data-id=\"c180a77\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<h4>Monographie du produit<\/h4><p>N\/A<\/p><p data-pm-slice=\"1 1 []\">La monographie est cr\u00e9\u00e9e par Sant\u00e9 Canada pour r\u00e9sumer les preuves qu&#8217;il a examin\u00e9es afin d&#8217;autoriser la vente de ce m\u00e9dicament aux patients au Canada. Elle comprend des informations sur l&#8217;indication du m\u00e9dicament (raison pour laquelle il est utilis\u00e9), ses effets secondaires et toute information relative aux avertissements de s\u00e9curit\u00e9. Ces informations sont utilis\u00e9es par les prescripteurs, les pharmaciens, les assureurs et d&#8217;autres personnes pour utiliser le m\u00e9dicament en toute s\u00e9curit\u00e9. Les informations peuvent \u00eatre tr\u00e8s d\u00e9taill\u00e9es et nous vous encourageons \u00e0 poser toutes les questions que vous souhaitez \u00e0 votre m\u00e9decin.   <\/p><p><strong>Ce site est r\u00e9guli\u00e8rement mis \u00e0 jour, mais ces informations sont susceptibles d&#8217;\u00eatre modifi\u00e9es. Pour obtenir les informations les plus r\u00e9centes concernant les <u><a class=\"ProsemirrorEditor-link\" href=\"https:\/\/www.canadianpsoriasisnetwork.com\/provincial-territorial-programs\/\">monographies<\/a><\/u> monographies de produits, <u><a class=\"ProsemirrorEditor-link\" href=\"https:\/\/health-products.canada.ca\/dpd-bdpp\/?lang=eng\">faites une recherche ici<\/a><\/u>. <\/strong><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/details>\n\t\t\t\t\t\t<details id=\"e-n-accordion-item-9645\" class=\"e-n-accordion-item\" >\n\t\t\t\t<summary class=\"e-n-accordion-item-title\" data-accordion-index=\"6\" tabindex=\"-1\" aria-expanded=\"false\" aria-controls=\"e-n-accordion-item-9645\" >\n\t\t\t\t\t<span class='e-n-accordion-item-title-header'><div class=\"e-n-accordion-item-title-text\"> Propionate d'halob\u00e9tasol et tazarot\u00e8ne (DUOBRII\u00ae) <\/div><\/span>\n\t\t\t\t\t\t\t<span class='e-n-accordion-item-title-icon'>\n\t\t\t<span class='e-opened' ><svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-minus\" viewBox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M416 208H32c-17.67 0-32 14.33-32 32v32c0 17.67 14.33 32 32 32h384c17.67 0 32-14.33 32-32v-32c0-17.67-14.33-32-32-32z\"><\/path><\/svg><\/span>\n\t\t\t<span class='e-closed'><svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-plus\" viewBox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M416 208H272V64c0-17.67-14.33-32-32-32h-32c-17.67 0-32 14.33-32 32v144H32c-17.67 0-32 14.33-32 32v32c0 17.67 14.33 32 32 32h144v144c0 17.67 14.33 32 32 32h32c17.67 0 32-14.33 32-32V304h144c17.67 0 32-14.33 32-32v-32c0-17.67-14.33-32-32-32z\"><\/path><\/svg><\/span>\n\t\t<\/span>\n\n\t\t\t\t\t\t<\/summary>\n\t\t\t\t<div role=\"region\" aria-labelledby=\"e-n-accordion-item-9645\" class=\"elementor-element elementor-element-e6f07d9 e-con-full e-flex e-con e-child\" data-id=\"e6f07d9\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t<div role=\"region\" aria-labelledby=\"e-n-accordion-item-9645\" class=\"elementor-element elementor-element-8bde545 e-flex e-con-boxed e-con e-child\" data-id=\"8bde545\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-b7ff77b elementor-widget elementor-widget-text-editor\" data-id=\"b7ff77b\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<h4>Comment cela fonctionne-t-il ?<\/h4><p><sup>DUOBRII\u00ae<\/sup> est une lotion utilis\u00e9e sur la peau pour am\u00e9liorer les signes et les sympt\u00f4mes du psoriasis chez les adultes.<\/p><p><sup>DUOBRII\u00ae<\/sup> est une association de deux m\u00e9dicaments diff\u00e9rents. Il contient du propionate d&#8217;halob\u00e9tasol, un corticost\u00e9ro\u00efde, et du tazarot\u00e8ne, un r\u00e9tino\u00efde topique. Le propionate d&#8217;halob\u00e9tasol a la capacit\u00e9 de r\u00e9duire l&#8217;inflammation de la peau. On pense que le tazarot\u00e8ne agit en contribuant \u00e0 la croissance normale des cellules de la peau et en r\u00e9duisant l&#8217;inflammation.   <\/p><h4>Comment est-il utilis\u00e9 ?<\/h4><p>Appliquez une fine couche une fois par jour sur la peau affect\u00e9e. Frottez doucement et lavez-vous les mains apr\u00e8s l&#8217;application. Lorsque votre psoriasis s&#8217;est am\u00e9lior\u00e9, cessez d&#8217;utiliser <sup>DUOBRIIMD<\/sup>. Vous pouvez alors l&#8217;utiliser de fa\u00e7on intermittente, au besoin, ou selon les directives de votre m\u00e9decin.   <\/p><h4>Quels sont les effets secondaires possibles ?<\/h4><p>Les effets secondaires les plus courants sont une dermatite de contact, une \u00e9ruption cutan\u00e9e ou des plaies. Veuillez consulter la <a href=\"https:\/\/pdf.hres.ca\/dpd_pm\/00056991.PDF\" target=\"_blank\" rel=\"noopener noreferrer\">monographie du produit<\/a> pour plus d&#8217;informations sur les effets secondaires. <\/p><p>L&#8217;utilisation prolong\u00e9e de ce produit peut entra\u00eener la suppression des glandes surr\u00e9nales. N&#8217;utilisez <sup>DUOBRII\u00ae<\/sup> que sous la supervision d&#8217;un m\u00e9decin. <\/p><h4>Y a-t-il d&#8217;autres points importants \u00e0 prendre en consid\u00e9ration ?<\/h4><p>N&#8217;utilisez pas <sup>DUOBRIIMD<\/sup>:<\/p><ul><li>Si vous \u00eates allergique au propionate d&#8217;halob\u00e9tasol, au tazarot\u00e8ne ou \u00e0 l&#8217;un des autres ingr\u00e9dients contenus dans <sup>DUOBRIIMD<\/sup>.<\/li><li>Si vous \u00eates allergique \u00e0 d&#8217;autres corticost\u00e9ro\u00efdes ou \u00e0 des compos\u00e9s r\u00e9tino\u00efques.<\/li><li>Sur certaines autres affections cutan\u00e9es (telles que les dermatites, les r\u00e9actions cutan\u00e9es apr\u00e8s un vaccin et les infections).<\/li><li>Si vous \u00eates enceinte ou si vous pensez l&#8217;\u00eatre.<\/li><\/ul><p>Le goudron de houille a une odeur et peut tacher la peau et les cheveux.<\/p><h4>Quels sont les m\u00e9dicaments qui interagissent avec ce traitement ?<\/h4><p>Aucune interaction m\u00e9dicamenteuse significative connue.<\/p><h4>Tableaux du formulaire du programme public de m\u00e9dicaments<\/h4>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-8c027a4 elementor-widget elementor-widget-shortcode\" data-id=\"8c027a4\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"shortcode.default\">\n\t\t\t\t\t\t\t<div class=\"elementor-shortcode\">\n<table id=\"tablepress-1-no-3\" class=\"tablepress tablepress-id-1\">\n<thead>\n<tr class=\"row-1\">\n\t<th class=\"column-1\">Province<\/th><th class=\"column-2\">Class<\/th><th class=\"column-3\">Generic name<\/th><th class=\"column-4\">Drug Name<\/th><th class=\"column-5\">Psoriasis<\/th><th class=\"column-6\">Psoriatic arthritis<\/th><th class=\"column-7\">GPP<\/th><th class=\"column-8\">monograph<\/th>\n<\/tr>\n<\/thead>\n<tbody class=\"row-striping row-hover\">\n<tr class=\"row-2\">\n\t<td class=\"column-1\">Alberta<\/td><td class=\"column-2\">Prescription Topical Treatments<\/td><td class=\"column-3\">Halobetasol propionate\u00a0and tazarotene<\/td><td class=\"column-4\">Duobrii\u00ae<\/td><td class=\"column-5\">SA<\/td><td class=\"column-6\">N\/A<\/td><td class=\"column-7\"><\/td><td class=\"column-8\">https:\/\/pdf.hres.ca\/dpd_pm\/00066402.PDF<\/td>\n<\/tr>\n<tr class=\"row-3\">\n\t<td class=\"column-1\">British Columbia<\/td><td class=\"column-2\">Prescription Topical Treatments<\/td><td class=\"column-3\">tazarotene and holobetasol <\/td><td class=\"column-4\">Duobrii\u00ae<\/td><td class=\"column-5\">SA<\/td><td class=\"column-6\">N\/A<\/td><td class=\"column-7\"><\/td><td class=\"column-8\">https:\/\/pdf.hres.ca\/dpd_pm\/00066402.PDF<\/td>\n<\/tr>\n<tr class=\"row-4\">\n\t<td class=\"column-1\">Manitoba<\/td><td class=\"column-2\">Prescription Topical Treatments<\/td><td class=\"column-3\">Halobetasol propionate\u00a0and tazarotene<\/td><td class=\"column-4\">Duobrii\u00ae<\/td><td class=\"column-5\">Yes<\/td><td class=\"column-6\">N\/A<\/td><td class=\"column-7\"><\/td><td class=\"column-8\">https:\/\/pdf.hres.ca\/dpd_pm\/00066402.PDF<\/td>\n<\/tr>\n<tr class=\"row-5\">\n\t<td class=\"column-1\">New Brunswick<\/td><td class=\"column-2\">Prescription Topical Treatments<\/td><td class=\"column-3\">Halobetasol propionate\u00a0and tazarotene<\/td><td class=\"column-4\">Duobrii\u00ae<\/td><td class=\"column-5\">Yes<\/td><td class=\"column-6\">N\/A<\/td><td class=\"column-7\"><\/td><td class=\"column-8\">https:\/\/pdf.hres.ca\/dpd_pm\/00066402.PDF<\/td>\n<\/tr>\n<tr class=\"row-6\">\n\t<td class=\"column-1\">Newfoundland and Labrador<\/td><td class=\"column-2\">Prescription Topical Treatments<\/td><td class=\"column-3\">Halobetasol propionate\u00a0and tazarotene<\/td><td class=\"column-4\">Duobrii\u00ae<\/td><td class=\"column-5\">SA<\/td><td class=\"column-6\">N\/A<\/td><td class=\"column-7\"><\/td><td class=\"column-8\">https:\/\/pdf.hres.ca\/dpd_pm\/00066402.PDF<\/td>\n<\/tr>\n<tr class=\"row-7\">\n\t<td class=\"column-1\">NIHB<\/td><td class=\"column-2\">Prescription Topical Treatments<\/td><td class=\"column-3\">Halobetasol propionate\u00a0and tazarotene<\/td><td class=\"column-4\">Duobrii\u00ae<\/td><td class=\"column-5\">Yes<\/td><td class=\"column-6\">N\/A<\/td><td class=\"column-7\"><\/td><td class=\"column-8\">https:\/\/pdf.hres.ca\/dpd_pm\/00066402.PDF<\/td>\n<\/tr>\n<tr class=\"row-8\">\n\t<td class=\"column-1\">Northwest Territories<\/td><td class=\"column-2\">Prescription Topical Treatments<\/td><td class=\"column-3\">Halobetasol propionate\u00a0and tazarotene<\/td><td class=\"column-4\">Duobrii\u00ae<\/td><td class=\"column-5\">Yes<\/td><td class=\"column-6\">N\/A<\/td><td class=\"column-7\"><\/td><td class=\"column-8\">https:\/\/pdf.hres.ca\/dpd_pm\/00066402.PDF<\/td>\n<\/tr>\n<tr class=\"row-9\">\n\t<td class=\"column-1\">Nova Scotia<\/td><td class=\"column-2\">Prescription Topical Treatments<\/td><td class=\"column-3\">Halobetasol propionate\u00a0and tazarotene<\/td><td class=\"column-4\">Duobrii\u00ae<\/td><td class=\"column-5\">SA<\/td><td class=\"column-6\">N\/A<\/td><td class=\"column-7\"><\/td><td class=\"column-8\">https:\/\/pdf.hres.ca\/dpd_pm\/00066402.PDF<\/td>\n<\/tr>\n<tr class=\"row-10\">\n\t<td class=\"column-1\">Nunavut<\/td><td class=\"column-2\">Prescription Topical Treatments<\/td><td class=\"column-3\">Halobetasol propionate\u00a0and tazarotene<\/td><td class=\"column-4\">Duobrii\u00ae<\/td><td class=\"column-5\">Yes<\/td><td class=\"column-6\">N\/A<\/td><td class=\"column-7\"><\/td><td class=\"column-8\">https:\/\/pdf.hres.ca\/dpd_pm\/00066402.PDF<\/td>\n<\/tr>\n<tr class=\"row-11\">\n\t<td class=\"column-1\">Ontario<\/td><td class=\"column-2\">Prescription Topical Treatments<\/td><td class=\"column-3\">Halobetasol propionate\u00a0and tazarotene<\/td><td class=\"column-4\">Duobrii\u00ae<\/td><td class=\"column-5\">Yes<\/td><td class=\"column-6\">N\/A<\/td><td class=\"column-7\"><\/td><td class=\"column-8\">https:\/\/pdf.hres.ca\/dpd_pm\/00066402.PDF<\/td>\n<\/tr>\n<tr class=\"row-12\">\n\t<td class=\"column-1\">Prince Edward Island<\/td><td class=\"column-2\">Prescription Topical Treatments<\/td><td class=\"column-3\">Halobetasol propionate\u00a0and tazarotene<\/td><td class=\"column-4\">Duobrii\u00ae<\/td><td class=\"column-5\">No<\/td><td class=\"column-6\">N\/A<\/td><td class=\"column-7\"><\/td><td class=\"column-8\">https:\/\/pdf.hres.ca\/dpd_pm\/00066402.PDF<\/td>\n<\/tr>\n<tr class=\"row-13\">\n\t<td class=\"column-1\">Quebec<\/td><td class=\"column-2\">Prescription Topical Treatments<\/td><td class=\"column-3\">Halobetasol propionate\u00a0and tazarotene<\/td><td class=\"column-4\">Duobrii\u00ae<\/td><td class=\"column-5\">Yes - S\/A<\/td><td class=\"column-6\">N\/A<\/td><td class=\"column-7\"><\/td><td class=\"column-8\">https:\/\/pdf.hres.ca\/dpd_pm\/00066402.PDF<\/td>\n<\/tr>\n<tr class=\"row-14\">\n\t<td class=\"column-1\">Saskatchewan<\/td><td class=\"column-2\">Prescription Topical Treatments<\/td><td class=\"column-3\">Halobetasol propionate\u00a0and tazarotene<\/td><td class=\"column-4\">Duobrii\u00ae<\/td><td class=\"column-5\">Yes<\/td><td class=\"column-6\">N\/A<\/td><td class=\"column-7\"><\/td><td class=\"column-8\">https:\/\/pdf.hres.ca\/dpd_pm\/00066402.PDF<\/td>\n<\/tr>\n<tr class=\"row-15\">\n\t<td class=\"column-1\">Yukon<\/td><td class=\"column-2\">Prescription Topical Treatments<\/td><td class=\"column-3\">Halobetasol propionate\u00a0and tazarotene<\/td><td class=\"column-4\">Duobrii\u00ae<\/td><td class=\"column-5\">No<\/td><td class=\"column-6\">N\/A<\/td><td class=\"column-7\"><\/td><td class=\"column-8\">https:\/\/pdf.hres.ca\/dpd_pm\/00066402.PDF<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<!-- #tablepress-1-no-3 from cache -->\n\n<!-- HFCM by 99 Robots - Snippet # 5: add formulary text -->\n<p>More information is available on S\/A (special access), L\/U (limited use) and Exceptional Drug Status (EDS) at\u00a0<a href=\"https:\/\/www.canadianpsoriasisnetwork.com\/treatments-canada\/special-access-drugs\/\" target=\"_blank\" rel=\"noopener\">Special Access \/ Limited Use Designation Drugs<\/a>.<\/p><p>NIHB stands for <a href=\"https:\/\/www.sac-isc.gc.ca\/eng\/1572537161086\/1572537234517\" target=\"_blank\" rel=\"noopener\">non-insured health benefits<\/a>.<\/p><p>This site is updated regularly; however this information is subject to change. Access may also vary depending on the specific plan. For the most up-to-date information regarding\u00a0<a href=\"https:\/\/www.canadianpsoriasisnetwork.com\/provincial-territorial-programs\/\" target=\"_blank\" rel=\"noopener\">your specific province \/ territory click here<\/a>.<\/p>\n<!-- \/end HFCM by 99 Robots -->\n<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-d884d3c elementor-widget elementor-widget-text-editor\" data-id=\"d884d3c\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<h4>Monographie du produit<\/h4><p><a href=\"https:\/\/pdf.hres.ca\/dpd_pm\/00066402.PDF\">https:\/\/pdf.hres.ca\/dpd_pm\/00066402.PDF<\/a><\/p><p data-pm-slice=\"1 1 []\">La monographie est cr\u00e9\u00e9e par Sant\u00e9 Canada pour r\u00e9sumer les preuves qu&#8217;il a examin\u00e9es afin d&#8217;autoriser la vente de ce m\u00e9dicament aux patients au Canada. Elle comprend des informations sur l&#8217;indication du m\u00e9dicament (raison pour laquelle il est utilis\u00e9), ses effets secondaires et toute information relative aux avertissements de s\u00e9curit\u00e9. Ces informations sont utilis\u00e9es par les prescripteurs, les pharmaciens, les assureurs et d&#8217;autres personnes pour utiliser le m\u00e9dicament en toute s\u00e9curit\u00e9. Les informations peuvent \u00eatre tr\u00e8s d\u00e9taill\u00e9es et nous vous encourageons \u00e0 poser toutes les questions que vous souhaitez \u00e0 votre m\u00e9decin.   <\/p><p><strong>Ce site est r\u00e9guli\u00e8rement mis \u00e0 jour, mais ces informations sont susceptibles d&#8217;\u00eatre modifi\u00e9es. Pour obtenir les informations les plus r\u00e9centes concernant les <u><a class=\"ProsemirrorEditor-link\" href=\"https:\/\/www.canadianpsoriasisnetwork.com\/provincial-territorial-programs\/\">monographies<\/a><\/u> monographies de produits, <u><a class=\"ProsemirrorEditor-link\" href=\"https:\/\/health-products.canada.ca\/dpd-bdpp\/?lang=eng\">faites une recherche ici<\/a><\/u>. <\/strong><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/details>\n\t\t\t\t\t\t<details id=\"e-n-accordion-item-9646\" class=\"e-n-accordion-item\" >\n\t\t\t\t<summary class=\"e-n-accordion-item-title\" data-accordion-index=\"7\" tabindex=\"-1\" aria-expanded=\"false\" aria-controls=\"e-n-accordion-item-9646\" >\n\t\t\t\t\t<span class='e-n-accordion-item-title-header'><div class=\"e-n-accordion-item-title-text\"> Lotion au propionate d'halob\u00e9tasol (Bryhali\u2122) <\/div><\/span>\n\t\t\t\t\t\t\t<span class='e-n-accordion-item-title-icon'>\n\t\t\t<span class='e-opened' ><svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-minus\" viewBox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M416 208H32c-17.67 0-32 14.33-32 32v32c0 17.67 14.33 32 32 32h384c17.67 0 32-14.33 32-32v-32c0-17.67-14.33-32-32-32z\"><\/path><\/svg><\/span>\n\t\t\t<span class='e-closed'><svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-plus\" viewBox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M416 208H272V64c0-17.67-14.33-32-32-32h-32c-17.67 0-32 14.33-32 32v144H32c-17.67 0-32 14.33-32 32v32c0 17.67 14.33 32 32 32h144v144c0 17.67 14.33 32 32 32h32c17.67 0 32-14.33 32-32V304h144c17.67 0 32-14.33 32-32v-32c0-17.67-14.33-32-32-32z\"><\/path><\/svg><\/span>\n\t\t<\/span>\n\n\t\t\t\t\t\t<\/summary>\n\t\t\t\t<div role=\"region\" aria-labelledby=\"e-n-accordion-item-9646\" class=\"elementor-element elementor-element-f7e7a99 e-con-full e-flex e-con e-child\" data-id=\"f7e7a99\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t<div role=\"region\" aria-labelledby=\"e-n-accordion-item-9646\" class=\"elementor-element elementor-element-9fea5c9 e-flex e-con-boxed e-con e-child\" data-id=\"9fea5c9\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-36e298b elementor-widget elementor-widget-text-editor\" data-id=\"36e298b\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<h4>Comment cela fonctionne-t-il ?<\/h4><p>Bryhali est un st\u00e9ro\u00efde topique, ce qui signifie qu&#8217;il arr\u00eate l&#8217;inflammation dans les zones o\u00f9 il est appliqu\u00e9, ce qui est utile pour traiter le psoriasis en plaques.<\/p><h4>Comment est-il utilis\u00e9 ?<\/h4><p>Bryhali est une cr\u00e8me qui s&#8217;applique sur les zones de la peau affect\u00e9es par le psoriasis en plaques. Bryhali ne doit g\u00e9n\u00e9ralement pas \u00eatre utilis\u00e9 pendant plus de 8 semaines. Il existe plusieurs zones de la peau sur lesquelles Bryhali ne doit pas \u00eatre appliqu\u00e9 en raison du risque de l\u00e9sions cutan\u00e9es. Par cons\u00e9quent, consultez toujours votre m\u00e9decin avant d&#8217;utiliser Bryhali afin de d\u00e9terminer la quantit\u00e9 appropri\u00e9e \u00e0 utiliser et la zone d&#8217;utilisation appropri\u00e9e.  <\/p><h4>Quels sont les effets secondaires possibles ?<\/h4><p>Les effets secondaires possibles de Bryhali comprennent une r\u00e9action de la peau sur laquelle la cr\u00e8me est appliqu\u00e9e, y compris un changement d&#8217;apparence de la peau ainsi qu&#8217;une sensation de br\u00fblure ou de d\u00e9mangeaison. Les effets secondaires moins fr\u00e9quents comprennent un risque accru d&#8217;infection, la toux et l&#8217;hypertension art\u00e9rielle. Pour obtenir une liste compl\u00e8te de tous les effets secondaires potentiels, consultez votre m\u00e9decin ou votre pharmacien.  <\/p><h4>Y a-t-il d&#8217;autres points importants \u00e0 prendre en consid\u00e9ration ?<\/h4><p>Bryhali ne doit pas \u00eatre utilis\u00e9 pendant plus de 8 semaines. Bryhali doit \u00eatre utilis\u00e9 avec prudence si vous avez des infections cutan\u00e9es ou des ant\u00e9c\u00e9dents d&#8217;hypertension art\u00e9rielle. <\/p><h4>Quels sont les m\u00e9dicaments qui interagissent avec ce traitement ?<\/h4><p>Il n&#8217;y a pas d&#8217;interactions m\u00e9dicamenteuses connues avec Bryhali, mais consultez toujours votre m\u00e9decin avant de commencer \u00e0 prendre Bryhali afin d&#8217;exclure toute possibilit\u00e9 d&#8217;interaction m\u00e9dicamenteuse.<\/p><h4>Tableaux du formulaire du programme public de m\u00e9dicaments<\/h4>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-1d3f356 elementor-widget elementor-widget-shortcode\" data-id=\"1d3f356\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"shortcode.default\">\n\t\t\t\t\t\t\t<div class=\"elementor-shortcode\">\n<table id=\"tablepress-1-no-4\" class=\"tablepress tablepress-id-1\">\n<thead>\n<tr class=\"row-1\">\n\t<th class=\"column-1\">Province<\/th><th class=\"column-2\">Class<\/th><th class=\"column-3\">Generic name<\/th><th class=\"column-4\">Drug Name<\/th><th class=\"column-5\">Psoriasis<\/th><th class=\"column-6\">Psoriatic arthritis<\/th><th class=\"column-7\">GPP<\/th><th class=\"column-8\">monograph<\/th>\n<\/tr>\n<\/thead>\n<tbody class=\"row-striping row-hover\">\n<tr class=\"row-2\">\n\t<td class=\"column-1\">Alberta<\/td><td class=\"column-2\">Prescription Topical Treatments<\/td><td class=\"column-3\">Halobetasol propionate<\/td><td class=\"column-4\">Bryhali<\/td><td class=\"column-5\"><\/td><td class=\"column-6\">N\/A<\/td><td class=\"column-7\"><\/td><td class=\"column-8\"><\/td>\n<\/tr>\n<tr class=\"row-3\">\n\t<td class=\"column-1\">British Columbia<\/td><td class=\"column-2\">Prescription Topical Treatments<\/td><td class=\"column-3\">Halobetasol propionate<\/td><td class=\"column-4\">Bryhali<\/td><td class=\"column-5\"><\/td><td class=\"column-6\">N\/A<\/td><td class=\"column-7\"><\/td><td class=\"column-8\"><\/td>\n<\/tr>\n<tr class=\"row-4\">\n\t<td class=\"column-1\">Manitoba<\/td><td class=\"column-2\">Prescription Topical Treatments<\/td><td class=\"column-3\">Halobetasol propionate<\/td><td class=\"column-4\">Bryhali<\/td><td class=\"column-5\"><\/td><td class=\"column-6\">N\/A<\/td><td class=\"column-7\"><\/td><td class=\"column-8\"><\/td>\n<\/tr>\n<tr class=\"row-5\">\n\t<td class=\"column-1\">New Brunswick<\/td><td class=\"column-2\">Prescription Topical Treatments<\/td><td class=\"column-3\">Halobetasol propionate<\/td><td class=\"column-4\">Bryhali<\/td><td class=\"column-5\"><\/td><td class=\"column-6\">N\/A<\/td><td class=\"column-7\"><\/td><td class=\"column-8\">https:\/\/pdf.hres.ca\/dpd_pm\/00041466.PDF<\/td>\n<\/tr>\n<tr class=\"row-6\">\n\t<td class=\"column-1\">Newfoundland and Labrador<\/td><td class=\"column-2\">Prescription Topical Treatments<\/td><td class=\"column-3\">Halobetasol propionate<\/td><td class=\"column-4\">Bryhali<\/td><td class=\"column-5\"><\/td><td class=\"column-6\">N\/A<\/td><td class=\"column-7\"><\/td><td class=\"column-8\"><\/td>\n<\/tr>\n<tr class=\"row-7\">\n\t<td class=\"column-1\">NIHB<\/td><td class=\"column-2\">Prescription Topical Treatments<\/td><td class=\"column-3\">Halobetasol propionate<\/td><td class=\"column-4\">Bryhali<\/td><td class=\"column-5\"><\/td><td class=\"column-6\">N\/A<\/td><td class=\"column-7\"><\/td><td class=\"column-8\"><\/td>\n<\/tr>\n<tr class=\"row-8\">\n\t<td class=\"column-1\">Northwest Territories<\/td><td class=\"column-2\">Prescription Topical Treatments<\/td><td class=\"column-3\">Halobetasol propionate<\/td><td class=\"column-4\">Bryhali<\/td><td class=\"column-5\"><\/td><td class=\"column-6\">N\/A<\/td><td class=\"column-7\"><\/td><td class=\"column-8\"><\/td>\n<\/tr>\n<tr class=\"row-9\">\n\t<td class=\"column-1\">Nova Scotia<\/td><td class=\"column-2\">Prescription Topical Treatments<\/td><td class=\"column-3\">Halobetasol propionate<\/td><td class=\"column-4\">Bryhali<\/td><td class=\"column-5\"><\/td><td class=\"column-6\">N\/A<\/td><td class=\"column-7\"><\/td><td class=\"column-8\"><\/td>\n<\/tr>\n<tr class=\"row-10\">\n\t<td class=\"column-1\">Nunavut<\/td><td class=\"column-2\">Prescription Topical Treatments<\/td><td class=\"column-3\">Halobetasol propionate<\/td><td class=\"column-4\">Bryhali<\/td><td class=\"column-5\"><\/td><td class=\"column-6\">N\/A<\/td><td class=\"column-7\"><\/td><td class=\"column-8\"><\/td>\n<\/tr>\n<tr class=\"row-11\">\n\t<td class=\"column-1\">Ontario<\/td><td class=\"column-2\">Prescription Topical Treatments<\/td><td class=\"column-3\">Halobetasol propionate<\/td><td class=\"column-4\">Bryhali<\/td><td class=\"column-5\"><\/td><td class=\"column-6\">N\/A<\/td><td class=\"column-7\"><\/td><td class=\"column-8\"><\/td>\n<\/tr>\n<tr class=\"row-12\">\n\t<td class=\"column-1\">Prince Edward Island<\/td><td class=\"column-2\">Prescription Topical Treatments<\/td><td class=\"column-3\">halobetasol propionate<\/td><td class=\"column-4\">Bryhali<\/td><td class=\"column-5\"><\/td><td class=\"column-6\">N\/A<\/td><td class=\"column-7\"><\/td><td class=\"column-8\"><\/td>\n<\/tr>\n<tr class=\"row-13\">\n\t<td class=\"column-1\">Quebec<\/td><td class=\"column-2\">Prescription Topical Treatments<\/td><td class=\"column-3\">Halobetasol propionate<\/td><td class=\"column-4\">Bryhali<\/td><td class=\"column-5\"><\/td><td class=\"column-6\">N\/A<\/td><td class=\"column-7\"><\/td><td class=\"column-8\"><\/td>\n<\/tr>\n<tr class=\"row-14\">\n\t<td class=\"column-1\">Saskatchewan<\/td><td class=\"column-2\">Prescription Topical Treatments<\/td><td class=\"column-3\">Halobetasol propionate<\/td><td class=\"column-4\">Bryhali<\/td><td class=\"column-5\"><\/td><td class=\"column-6\">N\/A<\/td><td class=\"column-7\"><\/td><td class=\"column-8\"><\/td>\n<\/tr>\n<tr class=\"row-15\">\n\t<td class=\"column-1\">Yukon<\/td><td class=\"column-2\">Prescription Topical Treatments<\/td><td class=\"column-3\">halobetasol propionate<\/td><td class=\"column-4\">Bryhali<\/td><td class=\"column-5\"><\/td><td class=\"column-6\">N\/A<\/td><td class=\"column-7\"><\/td><td class=\"column-8\"><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<!-- #tablepress-1-no-4 from cache -->\n\n<!-- HFCM by 99 Robots - Snippet # 5: add formulary text -->\n<p>More information is available on S\/A (special access), L\/U (limited use) and Exceptional Drug Status (EDS) at\u00a0<a href=\"https:\/\/www.canadianpsoriasisnetwork.com\/treatments-canada\/special-access-drugs\/\" target=\"_blank\" rel=\"noopener\">Special Access \/ Limited Use Designation Drugs<\/a>.<\/p><p>NIHB stands for <a href=\"https:\/\/www.sac-isc.gc.ca\/eng\/1572537161086\/1572537234517\" target=\"_blank\" rel=\"noopener\">non-insured health benefits<\/a>.<\/p><p>This site is updated regularly; however this information is subject to change. Access may also vary depending on the specific plan. For the most up-to-date information regarding\u00a0<a href=\"https:\/\/www.canadianpsoriasisnetwork.com\/provincial-territorial-programs\/\" target=\"_blank\" rel=\"noopener\">your specific province \/ territory click here<\/a>.<\/p>\n<!-- \/end HFCM by 99 Robots -->\n<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-c4084e4 elementor-widget elementor-widget-text-editor\" data-id=\"c4084e4\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p>Vous trouverez de plus amples informations sur le S\/A (acc\u00e8s sp\u00e9cial), le L\/U (usage limit\u00e9) et le statut de m\u00e9dicament d&#8217;exception (EDS) sur le site <a href=\"https:\/\/www.canadianpsoriasisnetwork.com\/treatments-canada\/special-access-drugs\/\" target=\"_blank\" rel=\"noopener\">Special Access \/ Limited Use Designation Drugs (acc\u00e8s sp\u00e9cial \/ usage limit\u00e9<\/a>).<\/p><p>L&#8217;acronyme NIHB d\u00e9signe les <a href=\"https:\/\/www.sac-isc.gc.ca\/eng\/1572537161086\/1572537234517\" target=\"_blank\" rel=\"noopener\">prestations de sant\u00e9 non assur\u00e9es<\/a>.<\/p><p>Ce site est r\u00e9guli\u00e8rement mis \u00e0 jour, mais ces informations sont susceptibles d&#8217;\u00eatre modifi\u00e9es. L&#8217;acc\u00e8s peut \u00e9galement varier en fonction du r\u00e9gime sp\u00e9cifique. Pour obtenir les informations les plus r\u00e9centes concernant <a href=\"https:\/\/www.canadianpsoriasisnetwork.com\/provincial-territorial-programs\/\" target=\"_blank\" rel=\"noopener\">votre province ou territoire, cliquez ici.<\/a>  <\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-ccc4edc elementor-widget elementor-widget-text-editor\" data-id=\"ccc4edc\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<h4>Monographie du produit<\/h4><p><a href=\"https:\/\/pdf.hres.ca\/dpd_pm\/00060714.PDF\">https:\/\/pdf.hres.ca\/dpd_pm\/00060714.PDF<\/a><\/p><p data-pm-slice=\"1 1 []\">La monographie est cr\u00e9\u00e9e par Sant\u00e9 Canada pour r\u00e9sumer les preuves qu&#8217;il a examin\u00e9es afin d&#8217;autoriser la vente de ce m\u00e9dicament aux patients au Canada. Elle comprend des informations sur l&#8217;indication du m\u00e9dicament (raison pour laquelle il est utilis\u00e9), ses effets secondaires et toute information relative aux avertissements de s\u00e9curit\u00e9. Ces informations sont utilis\u00e9es par les prescripteurs, les pharmaciens, les assureurs et d&#8217;autres personnes pour utiliser le m\u00e9dicament en toute s\u00e9curit\u00e9. Les informations peuvent \u00eatre tr\u00e8s d\u00e9taill\u00e9es et nous vous encourageons \u00e0 poser toutes les questions que vous souhaitez \u00e0 votre m\u00e9decin.   <\/p><p><strong>Ce site est r\u00e9guli\u00e8rement mis \u00e0 jour, mais ces informations sont susceptibles d&#8217;\u00eatre modifi\u00e9es. Pour obtenir les informations les plus r\u00e9centes concernant les <u><a class=\"ProsemirrorEditor-link\" href=\"https:\/\/www.canadianpsoriasisnetwork.com\/provincial-territorial-programs\/\">monographies<\/a><\/u> monographies de produits, <u><a class=\"ProsemirrorEditor-link\" href=\"https:\/\/health-products.canada.ca\/dpd-bdpp\/?lang=eng\">faites une recherche ici<\/a><\/u>. <\/strong><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/details>\n\t\t\t\t\t\t<details id=\"e-n-accordion-item-9647\" class=\"e-n-accordion-item\" >\n\t\t\t\t<summary class=\"e-n-accordion-item-title\" data-accordion-index=\"8\" tabindex=\"-1\" aria-expanded=\"false\" aria-controls=\"e-n-accordion-item-9647\" >\n\t\t\t\t\t<span class='e-n-accordion-item-title-header'><div class=\"e-n-accordion-item-title-text\"> Roflumilast (ZORYVE\u2122) <\/div><\/span>\n\t\t\t\t\t\t\t<span class='e-n-accordion-item-title-icon'>\n\t\t\t<span class='e-opened' ><svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-minus\" viewBox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M416 208H32c-17.67 0-32 14.33-32 32v32c0 17.67 14.33 32 32 32h384c17.67 0 32-14.33 32-32v-32c0-17.67-14.33-32-32-32z\"><\/path><\/svg><\/span>\n\t\t\t<span class='e-closed'><svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-plus\" viewBox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M416 208H272V64c0-17.67-14.33-32-32-32h-32c-17.67 0-32 14.33-32 32v144H32c-17.67 0-32 14.33-32 32v32c0 17.67 14.33 32 32 32h144v144c0 17.67 14.33 32 32 32h32c17.67 0 32-14.33 32-32V304h144c17.67 0 32-14.33 32-32v-32c0-17.67-14.33-32-32-32z\"><\/path><\/svg><\/span>\n\t\t<\/span>\n\n\t\t\t\t\t\t<\/summary>\n\t\t\t\t<div role=\"region\" aria-labelledby=\"e-n-accordion-item-9647\" class=\"elementor-element elementor-element-854e01a e-con-full e-flex e-con e-child\" data-id=\"854e01a\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t<div role=\"region\" aria-labelledby=\"e-n-accordion-item-9647\" class=\"elementor-element elementor-element-4e716b8 e-flex e-con-boxed e-con e-child\" data-id=\"4e716b8\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-d6ad5e3 elementor-widget elementor-widget-text-editor\" data-id=\"d6ad5e3\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<h4>Comment cela fonctionne-t-il ?<\/h4><p>Le roflumilast est un inhibiteur s\u00e9lectif non st\u00e9ro\u00efdien de la phosphodiest\u00e9rase 4 (PDE4), utilis\u00e9 pour le traitement topique du psoriasis en plaques, y compris le traitement du psoriasis dans les zones intertrigineuses, chez les patients \u00e2g\u00e9s de 12 ans et plus.<\/p><h4>Comment est-il utilis\u00e9 ?<\/h4><p class=\"p1\">Appliquez le roflumilast par voie topique une fois par jour sur les zones affect\u00e9es de la peau et faites-le p\u00e9n\u00e9trer compl\u00e8tement. Lavez-vous les mains apr\u00e8s l&#8217;application, \u00e0 moins que les mains ne soient les zones affect\u00e9es par le traitement. <\/p><p class=\"p1\">Si l&#8217;utilisation pendant l&#8217;allaitement est jug\u00e9e m\u00e9dicalement n\u00e9cessaire, utilisez le roflumilast sur la plus petite surface de la peau pendant la dur\u00e9e la plus courte possible. N&#8217;appliquez pas le roflumilast directement sur le mamelon et l&#8217;ar\u00e9ole afin d&#8217;\u00e9viter une exposition directe du nourrisson. <\/p><p class=\"p1\">Le roflumilast est destin\u00e9 uniquement \u00e0 un usage topique et non \u00e0 un usage ophtalmique, oral ou intravaginal.<\/p><h4>Quels sont les effets secondaires possibles ?<\/h4><p>Les effets ind\u00e9sirables les plus fr\u00e9quemment rapport\u00e9s dans les essais cliniques chez les patients atteints de psoriasis en plaques \u00e2g\u00e9s de 12 ans et plus sont la diarrh\u00e9e et les maux de t\u00eate. Pour obtenir une liste compl\u00e8te de tous les effets secondaires potentiels connus du roflumilast, consultez votre m\u00e9decin ou votre pharmacien. <\/p><h4>Y a-t-il d&#8217;autres points importants \u00e0 prendre en consid\u00e9ration ?<\/h4><p class=\"p1\">Le roflumilast est contre-indiqu\u00e9 chez les patients pr\u00e9sentant une insuffisance h\u00e9patique mod\u00e9r\u00e9e \u00e0 s\u00e9v\u00e8re (Child-Pugh B ou C) et chez les patients pr\u00e9sentant une hypersensibilit\u00e9 \u00e0 ce m\u00e9dicament ou \u00e0 l&#8217;un des ingr\u00e9dients de la formulation, y compris tout ingr\u00e9dient non m\u00e9dicinal, ou aux composants du contenant.<\/p><p class=\"p1\">Le roflumilast ne doit pas \u00eatre utilis\u00e9 pendant le travail et l&#8217;accouchement. Le roflumilast ne doit \u00eatre utilis\u00e9 par une m\u00e8re qui allaite que si cela est jug\u00e9 m\u00e9dicalement n\u00e9cessaire, compte tenu du risque potentiel pour l&#8217;enfant. Pour minimiser l&#8217;exposition potentielle de l&#8217;enfant allait\u00e9 par le lait maternel, utilisez le roflumilast sur la plus petite surface de peau et pendant la dur\u00e9e la plus courte possible pendant l&#8217;allaitement. N&#8217;appliquez pas le roflumilast directement sur le mamelon et l&#8217;ar\u00e9ole afin d&#8217;\u00e9viter une exposition directe du nourrisson.   <\/p><h4>Quels sont les m\u00e9dicaments qui interagissent avec ce traitement ?<\/h4><p>Aucune \u00e9tude formelle d&#8217;interaction m\u00e9dicamenteuse n&#8217;a \u00e9t\u00e9 men\u00e9e avec le roflumilast. Pour obtenir une liste compl\u00e8te des m\u00e9dicaments susceptibles d&#8217;interagir avec le roflumilast et comprendre comment g\u00e9rer une interaction m\u00e9dicamenteuse potentielle, consultez votre m\u00e9decin ou votre pharmacien. <\/p><h4>Tableaux du formulaire du programme public de m\u00e9dicaments<\/h4>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-c79d7ab elementor-widget elementor-widget-shortcode\" data-id=\"c79d7ab\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"shortcode.default\">\n\t\t\t\t\t\t\t<div class=\"elementor-shortcode\">\n<table id=\"tablepress-1-no-5\" class=\"tablepress tablepress-id-1\">\n<thead>\n<tr class=\"row-1\">\n\t<th class=\"column-1\">Province<\/th><th class=\"column-2\">Class<\/th><th class=\"column-3\">Generic name<\/th><th class=\"column-4\">Drug Name<\/th><th class=\"column-5\">Psoriasis<\/th><th class=\"column-6\">Psoriatic arthritis<\/th><th class=\"column-7\">GPP<\/th><th class=\"column-8\">monograph<\/th>\n<\/tr>\n<\/thead>\n<tbody class=\"row-striping row-hover\">\n<tr class=\"row-2\">\n\t<td class=\"column-1\">Alberta<\/td><td class=\"column-2\">Prescription Topical Treatments<\/td><td class=\"column-3\">Roflumilast <\/td><td class=\"column-4\">Zoryve<\/td><td class=\"column-5\">No<\/td><td class=\"column-6\">N\/A<\/td><td class=\"column-7\"><\/td><td class=\"column-8\"><\/td>\n<\/tr>\n<tr class=\"row-3\">\n\t<td class=\"column-1\">British Columbia<\/td><td class=\"column-2\">Prescription Topical Treatments<\/td><td class=\"column-3\">Roflumilast <\/td><td class=\"column-4\">Zoryve<\/td><td class=\"column-5\">No<\/td><td class=\"column-6\">N\/A<\/td><td class=\"column-7\"><\/td><td class=\"column-8\"><\/td>\n<\/tr>\n<tr class=\"row-4\">\n\t<td class=\"column-1\">Manitoba<\/td><td class=\"column-2\">Prescription Topical Treatments<\/td><td class=\"column-3\">Roflumilast <\/td><td class=\"column-4\">Zoryve<\/td><td class=\"column-5\">No<\/td><td class=\"column-6\">N\/A<\/td><td class=\"column-7\"><\/td><td class=\"column-8\"><\/td>\n<\/tr>\n<tr class=\"row-5\">\n\t<td class=\"column-1\">New Brunswick<\/td><td class=\"column-2\">Prescription Topical Treatments<\/td><td class=\"column-3\">Roflumilast <\/td><td class=\"column-4\">Zoryve<\/td><td class=\"column-5\">No<\/td><td class=\"column-6\">N\/A<\/td><td class=\"column-7\"><\/td><td class=\"column-8\"><\/td>\n<\/tr>\n<tr class=\"row-6\">\n\t<td class=\"column-1\">Newfoundland and Labrador<\/td><td class=\"column-2\">Prescription Topical Treatments<\/td><td class=\"column-3\">Roflumilast <\/td><td class=\"column-4\">Zoryve<\/td><td class=\"column-5\">No<\/td><td class=\"column-6\">N\/A<\/td><td class=\"column-7\"><\/td><td class=\"column-8\"><\/td>\n<\/tr>\n<tr class=\"row-7\">\n\t<td class=\"column-1\">NIHB<\/td><td class=\"column-2\">Prescription Topical Treatments<\/td><td class=\"column-3\">Roflumilast <\/td><td class=\"column-4\">Zoryve<\/td><td class=\"column-5\">No<\/td><td class=\"column-6\">N\/A<\/td><td class=\"column-7\"><\/td><td class=\"column-8\"><\/td>\n<\/tr>\n<tr class=\"row-8\">\n\t<td class=\"column-1\">Northwest Territories<\/td><td class=\"column-2\">Prescription Topical Treatments<\/td><td class=\"column-3\">Roflumilast <\/td><td class=\"column-4\">Zoryve<\/td><td class=\"column-5\">No<\/td><td class=\"column-6\">N\/A<\/td><td class=\"column-7\"><\/td><td class=\"column-8\"><\/td>\n<\/tr>\n<tr class=\"row-9\">\n\t<td class=\"column-1\">Nova Scotia<\/td><td class=\"column-2\">Prescription Topical Treatments<\/td><td class=\"column-3\">Roflumilast <\/td><td class=\"column-4\">Zoryve<\/td><td class=\"column-5\">No<\/td><td class=\"column-6\">N\/A<\/td><td class=\"column-7\"><\/td><td class=\"column-8\"><\/td>\n<\/tr>\n<tr class=\"row-10\">\n\t<td class=\"column-1\">Nunavut<\/td><td class=\"column-2\">Prescription Topical Treatments<\/td><td class=\"column-3\">Roflumilast <\/td><td class=\"column-4\">Zoryve<\/td><td class=\"column-5\">No<\/td><td class=\"column-6\">N\/A<\/td><td class=\"column-7\"><\/td><td class=\"column-8\"><\/td>\n<\/tr>\n<tr class=\"row-11\">\n\t<td class=\"column-1\">Prince Edward Island<\/td><td class=\"column-2\">Prescription Topical Treatments<\/td><td class=\"column-3\">Roflumilast <\/td><td class=\"column-4\">Zoryve<\/td><td class=\"column-5\">No<\/td><td class=\"column-6\">N\/A<\/td><td class=\"column-7\"><\/td><td class=\"column-8\"><\/td>\n<\/tr>\n<tr class=\"row-12\">\n\t<td class=\"column-1\">Quebec<\/td><td class=\"column-2\">Prescription Topical Treatments<\/td><td class=\"column-3\">Roflumilast <\/td><td class=\"column-4\">Zoryve<\/td><td class=\"column-5\">No<\/td><td class=\"column-6\">N\/A<\/td><td class=\"column-7\"><\/td><td class=\"column-8\"><\/td>\n<\/tr>\n<tr class=\"row-13\">\n\t<td class=\"column-1\">Saskatchewan<\/td><td class=\"column-2\">Prescription Topical Treatments<\/td><td class=\"column-3\">Roflumilast <\/td><td class=\"column-4\">Zoryve<\/td><td class=\"column-5\">No<\/td><td class=\"column-6\">N\/A<\/td><td class=\"column-7\"><\/td><td class=\"column-8\"><\/td>\n<\/tr>\n<tr class=\"row-14\">\n\t<td class=\"column-1\">Yukon<\/td><td class=\"column-2\">Prescription Topical Treatments<\/td><td class=\"column-3\">Roflumilast <\/td><td class=\"column-4\">Zoryve<\/td><td class=\"column-5\">No<\/td><td class=\"column-6\">N\/A<\/td><td class=\"column-7\"><\/td><td class=\"column-8\"><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<!-- #tablepress-1-no-5 from cache -->\n\n<!-- HFCM by 99 Robots - Snippet # 5: add formulary text -->\n<p>More information is available on S\/A (special access), L\/U (limited use) and Exceptional Drug Status (EDS) at\u00a0<a href=\"https:\/\/www.canadianpsoriasisnetwork.com\/treatments-canada\/special-access-drugs\/\" target=\"_blank\" rel=\"noopener\">Special Access \/ Limited Use Designation Drugs<\/a>.<\/p><p>NIHB stands for <a href=\"https:\/\/www.sac-isc.gc.ca\/eng\/1572537161086\/1572537234517\" target=\"_blank\" rel=\"noopener\">non-insured health benefits<\/a>.<\/p><p>This site is updated regularly; however this information is subject to change. Access may also vary depending on the specific plan. For the most up-to-date information regarding\u00a0<a href=\"https:\/\/www.canadianpsoriasisnetwork.com\/provincial-territorial-programs\/\" target=\"_blank\" rel=\"noopener\">your specific province \/ territory click here<\/a>.<\/p>\n<!-- \/end HFCM by 99 Robots -->\n<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-46dd5aa elementor-widget elementor-widget-text-editor\" data-id=\"46dd5aa\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p>Vous trouverez de plus amples informations sur S\/A (acc\u00e8s sp\u00e9cial), L\/U (usage limit\u00e9) et le statut de m\u00e9dicament d&#8217;exception (EDS) sur le site <a href=\"https:\/\/www.canadianpsoriasisnetwork.com\/treatments-canada\/special-access-drugs\/\" target=\"_blank\" rel=\"noopener\">Special Access \/ Limited Use Designation Drugs (acc\u00e8s sp\u00e9cial \/ usage limit\u00e9)<\/a>.<\/p><p>L&#8217;acronyme NIHB d\u00e9signe les <a href=\"https:\/\/www.sac-isc.gc.ca\/eng\/1572537161086\/1572537234517\" target=\"_blank\" rel=\"noopener\">prestations de sant\u00e9 non assur\u00e9es<\/a>.<\/p><p>Ce site est r\u00e9guli\u00e8rement mis \u00e0 jour, mais ces informations sont susceptibles d&#8217;\u00eatre modifi\u00e9es. L&#8217;acc\u00e8s peut \u00e9galement varier en fonction du r\u00e9gime sp\u00e9cifique. Pour obtenir les informations les plus r\u00e9centes concernant <a href=\"https:\/\/www.canadianpsoriasisnetwork.com\/provincial-territorial-programs\/\" target=\"_blank\" rel=\"noopener\">votre province ou territoire, cliquez ici.<\/a>  <\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-8b78961 elementor-widget elementor-widget-text-editor\" data-id=\"8b78961\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<h4>Monographie du produit<\/h4><p><a href=\"https:\/\/pdf.hres.ca\/dpd_pm\/00060714.PDF\">https:\/\/pdf.hres.ca\/dpd_pm\/00060714.PDF<\/a><\/p><p data-pm-slice=\"1 1 []\">La monographie est cr\u00e9\u00e9e par Sant\u00e9 Canada pour r\u00e9sumer les preuves qu&#8217;il a examin\u00e9es afin d&#8217;autoriser la vente de ce m\u00e9dicament aux patients au Canada. Elle comprend des informations sur l&#8217;indication du m\u00e9dicament (raison pour laquelle il est utilis\u00e9), ses effets secondaires et toute information relative aux avertissements de s\u00e9curit\u00e9. Ces informations sont utilis\u00e9es par les prescripteurs, les pharmaciens, les assureurs et d&#8217;autres personnes pour utiliser le m\u00e9dicament en toute s\u00e9curit\u00e9. Les informations peuvent \u00eatre tr\u00e8s d\u00e9taill\u00e9es et nous vous encourageons \u00e0 poser toutes les questions que vous souhaitez \u00e0 votre m\u00e9decin.   <\/p><p><strong>Ce site est r\u00e9guli\u00e8rement mis \u00e0 jour, mais ces informations sont susceptibles d&#8217;\u00eatre modifi\u00e9es. Pour obtenir les informations les plus r\u00e9centes concernant les <u><a class=\"ProsemirrorEditor-link\" href=\"https:\/\/www.canadianpsoriasisnetwork.com\/provincial-territorial-programs\/\">monographies<\/a><\/u> monographies de produits, <u><a class=\"ProsemirrorEditor-link\" href=\"https:\/\/health-products.canada.ca\/dpd-bdpp\/?lang=eng\">faites une recherche ici<\/a><\/u>. <\/strong><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/details>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-e6a32a5 e-flex e-con-boxed e-con e-parent\" data-id=\"e6a32a5\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-5ae8a5c elementor-widget elementor-widget-text-editor\" data-id=\"5ae8a5c\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p><em>Derni\u00e8re mise \u00e0 jour le 31 mai 2024.<\/em><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Applications topiques Un \u00e9mollient est un ingr\u00e9dient pr\u00e9sent dans les traitements topiques pour adoucir et apaiser la peau. Ils constituent des options de traitement pr\u00e9cieuses et peu co\u00fbteuses pour de nombreuses personnes atteintes de psoriasis l\u00e9ger \u00e0 mod\u00e9r\u00e9. Lorsque le psoriasis est plus grave, les solutions topiques sont susceptibles d\u2019\u00eatre associ\u00e9es \u00e0 des m\u00e9dicaments par [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":1379,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"website_toolbox_forum_postUrl":"","website_toolbox_forum_category":"","website_toolbox_publish_on_forum":"","footnotes":""},"class_list":["post-1388","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Applications topiques - Psoriasis Canada<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/psoriasiscanada.ca\/fr\/traitements-traiter-le-pso-et-le-psa-vue-densemble\/applications-topiques\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Applications topiques - Psoriasis Canada\" \/>\n<meta property=\"og:description\" content=\"Applications topiques Un \u00e9mollient est un ingr\u00e9dient pr\u00e9sent dans les traitements topiques pour adoucir et apaiser la peau. Ils constituent des options de traitement pr\u00e9cieuses et peu co\u00fbteuses pour de nombreuses personnes atteintes de psoriasis l\u00e9ger \u00e0 mod\u00e9r\u00e9. Lorsque le psoriasis est plus grave, les solutions topiques sont susceptibles d\u2019\u00eatre associ\u00e9es \u00e0 des m\u00e9dicaments par [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/psoriasiscanada.ca\/fr\/traitements-traiter-le-pso-et-le-psa-vue-densemble\/applications-topiques\/\" \/>\n<meta property=\"og:site_name\" content=\"Psoriasis Canada\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/PsoriasisCan1\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-19T18:50:21+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"40 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/psoriasiscanada.ca\\\/fr\\\/traitements-traiter-le-pso-et-le-psa-vue-densemble\\\/applications-topiques\\\/\",\"url\":\"https:\\\/\\\/psoriasiscanada.ca\\\/fr\\\/traitements-traiter-le-pso-et-le-psa-vue-densemble\\\/applications-topiques\\\/\",\"name\":\"Applications topiques - Psoriasis Canada\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/psoriasiscanada.ca\\\/#website\"},\"datePublished\":\"2026-01-20T19:06:38+00:00\",\"dateModified\":\"2026-03-19T18:50:21+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/psoriasiscanada.ca\\\/fr\\\/traitements-traiter-le-pso-et-le-psa-vue-densemble\\\/applications-topiques\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/psoriasiscanada.ca\\\/fr\\\/traitements-traiter-le-pso-et-le-psa-vue-densemble\\\/applications-topiques\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/psoriasiscanada.ca\\\/fr\\\/traitements-traiter-le-pso-et-le-psa-vue-densemble\\\/applications-topiques\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/psoriasiscanada.ca\\\/fr\\\/home\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Traitements &#8211; Traiter le Pso et le PsA &#8211; Vue d&#8217;ensemble\",\"item\":\"https:\\\/\\\/psoriasiscanada.ca\\\/fr\\\/traitements-traiter-le-pso-et-le-psa-vue-densemble\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Applications topiques\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/psoriasiscanada.ca\\\/#website\",\"url\":\"https:\\\/\\\/psoriasiscanada.ca\\\/\",\"name\":\"Psoriasis Canada\",\"description\":\"Psoriasis Canada\",\"publisher\":{\"@id\":\"https:\\\/\\\/psoriasiscanada.ca\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/psoriasiscanada.ca\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/psoriasiscanada.ca\\\/#organization\",\"name\":\"Psoriasis Canada\",\"url\":\"https:\\\/\\\/psoriasiscanada.ca\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/psoriasiscanada.ca\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/psoriasiscanada.ca\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/logo.png\",\"contentUrl\":\"https:\\\/\\\/psoriasiscanada.ca\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/logo.png\",\"width\":222,\"height\":73,\"caption\":\"Psoriasis Canada\"},\"image\":{\"@id\":\"https:\\\/\\\/psoriasiscanada.ca\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/PsoriasisCan1\",\"https:\\\/\\\/www.linkedin.com\\\/in\\\/psoriasiscan1\",\"https:\\\/\\\/www.youtube.com\\\/@PsoriasisCan1\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Applications topiques - Psoriasis Canada","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/psoriasiscanada.ca\/fr\/traitements-traiter-le-pso-et-le-psa-vue-densemble\/applications-topiques\/","og_locale":"fr_FR","og_type":"article","og_title":"Applications topiques - Psoriasis Canada","og_description":"Applications topiques Un \u00e9mollient est un ingr\u00e9dient pr\u00e9sent dans les traitements topiques pour adoucir et apaiser la peau. Ils constituent des options de traitement pr\u00e9cieuses et peu co\u00fbteuses pour de nombreuses personnes atteintes de psoriasis l\u00e9ger \u00e0 mod\u00e9r\u00e9. Lorsque le psoriasis est plus grave, les solutions topiques sont susceptibles d\u2019\u00eatre associ\u00e9es \u00e0 des m\u00e9dicaments par [&hellip;]","og_url":"https:\/\/psoriasiscanada.ca\/fr\/traitements-traiter-le-pso-et-le-psa-vue-densemble\/applications-topiques\/","og_site_name":"Psoriasis Canada","article_publisher":"https:\/\/www.facebook.com\/PsoriasisCan1","article_modified_time":"2026-03-19T18:50:21+00:00","twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"40 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/psoriasiscanada.ca\/fr\/traitements-traiter-le-pso-et-le-psa-vue-densemble\/applications-topiques\/","url":"https:\/\/psoriasiscanada.ca\/fr\/traitements-traiter-le-pso-et-le-psa-vue-densemble\/applications-topiques\/","name":"Applications topiques - Psoriasis Canada","isPartOf":{"@id":"https:\/\/psoriasiscanada.ca\/#website"},"datePublished":"2026-01-20T19:06:38+00:00","dateModified":"2026-03-19T18:50:21+00:00","breadcrumb":{"@id":"https:\/\/psoriasiscanada.ca\/fr\/traitements-traiter-le-pso-et-le-psa-vue-densemble\/applications-topiques\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/psoriasiscanada.ca\/fr\/traitements-traiter-le-pso-et-le-psa-vue-densemble\/applications-topiques\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/psoriasiscanada.ca\/fr\/traitements-traiter-le-pso-et-le-psa-vue-densemble\/applications-topiques\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/psoriasiscanada.ca\/fr\/home\/"},{"@type":"ListItem","position":2,"name":"Traitements &#8211; Traiter le Pso et le PsA &#8211; Vue d&#8217;ensemble","item":"https:\/\/psoriasiscanada.ca\/fr\/traitements-traiter-le-pso-et-le-psa-vue-densemble\/"},{"@type":"ListItem","position":3,"name":"Applications topiques"}]},{"@type":"WebSite","@id":"https:\/\/psoriasiscanada.ca\/#website","url":"https:\/\/psoriasiscanada.ca\/","name":"Psoriasis Canada","description":"Psoriasis Canada","publisher":{"@id":"https:\/\/psoriasiscanada.ca\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/psoriasiscanada.ca\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/psoriasiscanada.ca\/#organization","name":"Psoriasis Canada","url":"https:\/\/psoriasiscanada.ca\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/psoriasiscanada.ca\/#\/schema\/logo\/image\/","url":"https:\/\/psoriasiscanada.ca\/wp-content\/uploads\/2025\/11\/logo.png","contentUrl":"https:\/\/psoriasiscanada.ca\/wp-content\/uploads\/2025\/11\/logo.png","width":222,"height":73,"caption":"Psoriasis Canada"},"image":{"@id":"https:\/\/psoriasiscanada.ca\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/PsoriasisCan1","https:\/\/www.linkedin.com\/in\/psoriasiscan1","https:\/\/www.youtube.com\/@PsoriasisCan1"]}]}},"_links":{"self":[{"href":"https:\/\/psoriasiscanada.ca\/fr\/wp-json\/wp\/v2\/pages\/1388","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/psoriasiscanada.ca\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/psoriasiscanada.ca\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/psoriasiscanada.ca\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/psoriasiscanada.ca\/fr\/wp-json\/wp\/v2\/comments?post=1388"}],"version-history":[{"count":5,"href":"https:\/\/psoriasiscanada.ca\/fr\/wp-json\/wp\/v2\/pages\/1388\/revisions"}],"predecessor-version":[{"id":1411,"href":"https:\/\/psoriasiscanada.ca\/fr\/wp-json\/wp\/v2\/pages\/1388\/revisions\/1411"}],"up":[{"embeddable":true,"href":"https:\/\/psoriasiscanada.ca\/fr\/wp-json\/wp\/v2\/pages\/1379"}],"wp:attachment":[{"href":"https:\/\/psoriasiscanada.ca\/fr\/wp-json\/wp\/v2\/media?parent=1388"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}